Surface proteomics data
Which proteins have published experiments actually found on the outside of human cells? We collected 348 datasets from 228 cell-surface proteomics papers and matched every reported protein to its UniProt accession. 92 datasets from 84 papers pass our quality review (see “How to interpret these datasets”) and count as surface evidence; together they detect 11,662 proteins. The other 256 are listed for completeness and marked as not counted.
Those totals count each study's baseline samples only. The 86 other-condition datasets (senescent, infected, knockout, treated or diseased samples of the same studies) are not counted by default. Counting the 37 whose study's baseline dataset passes review gives 129 datasets from 84 papers detecting 11,690 proteins; the “Also count other conditions” switch below applies that rule to the study table and every view.
The compendium covers whole-surface measurements: labeling of exposed proteins on intact cells, and membrane fractionation. It does not include targeted membrane enrichment of chosen proteins, such as proximity labeling around a single bait, antibody or affinity pulldowns, or lists restricted to a target panel.
Download: every protein × dataset (TSV, 18,813 rows) · dataset details (TSV, 348 rows) · methods and source detail (TSV, 348 rows)
How to interpret these datasets what counts as surface evidence, methods, scores and Surfaceome tiers
What our quality review checks
A dataset counts as surface evidence only if it passes all five checks, judged from each paper's methods section and supplementary tables. The reading is AI-assisted and still under review; report an error to surfaceome-viewer@deliverome.org.
- Human cells or tissue. Non-human proteins and samples are excluded before anything else.
- Labeled on intact, living cells. The tag (biotin, glycan capture, proximity label) went on before the cells were broken open, so it could only reach proteins facing outward. Membrane fractionation and labels that reach inside the cell fail this check. 78 datasets → Membrane fraction
- Mostly surface proteins, not background. When the published table reports per-protein amounts (intensities or spectral counts), at least 25% of the dataset's total amount must be established surface proteins, meaning Canonical or Likely in our Surfaceome. Each protein's amount is divided by its length first, so the share counts molecules and a long protein is not favored. A deep list picks up many faint intracellular proteins, so judging by amount keeps it from being penalized for depth. The bar passes as many membrane preparations as the list screen does. When the table reports no usable amounts, at least 20% of the dataset's proteins must be established surface proteins, and a list within 2 points below that counts only as Provisional. (A random set of human proteins scores about 15%.) When the authors pre-filtered their list to annotated surface proteins, the bar is raised to match — though such a list is not counted either way, so the raised bar only decides whether it lands here or under “Pre-filtered by surface annotation” below. 39 datasets → High background
- Readable per protein. The published table has to say which proteins were detected. Tables that pool conditions with no separable baseline, or where the baseline sample can't be identified, fail. Imputed values alone do not hold an arm: when every row passed the authors' identification filters, presence in the study is counted (provisional), though per-sample detection is not available. 32 datasets → Held
- Not pre-filtered by surface annotation. Pre-filtered by surface annotation (shown, not counted): the published table was already restricted to proteins annotated or predicted as surface or membrane proteins. Such a table cannot add a candidate or reveal a miss, and it would inflate the share of known surface proteins that the quality screen measures, so it is shown, cited only as support for proteins already in the reference, and never counted. 21 datasets → Pre-filtered by surface annotation
Datasets that pass are Core (86), or Provisional (6) when they pass with a caveat, such as sitting within two points of the 20% list bar or having no no-label control. Both count.
A study counts only its baseline samples: untreated, wild-type, uninfected or healthy. When it also measured the same cells after a change of state (senescence, infection, a knockout, a drug, a disease), that condition is listed as its own Other condition dataset (86), not counted by default. A reader can switch on “Also count other conditions”, which counts one only when its study's baseline dataset passes review. A condition is not listed when the published table reports every protein in every sample, as multiplexed tables do, because it would only repeat the baseline list.
Data snapshot 2026-11-18-abundance-v5, built 2026-11-19.
Method
- Intact-cell labeling
- Proteins are tagged on living, unbroken cells (biotinylation, glycan capture, proximity labeling), so a tag can only reach what faces outward. This is the only method family we count as evidence that a protein is reachable from outside the cell.
- Membrane fractionation
- Cells are broken open and membranes are purified. This shows that a protein is membrane-associated, including on internal membranes, not that it is exposed on the outer surface.
Review status
- Core counted 86 datasets
- Intact-cell labeling that passes the surface screen: at least 25% of its length-corrected protein amount is Canonical or Likely Surfaceome proteins when the table reports amounts, otherwise at least 20% of its protein list. Counts as surface evidence.
- Provisional counted 6 datasets
- Intact-cell labeling that passes with a caveat: it sits within 2 points below the 20% list screen (18–20%), it has no no-label control, it was built from a partial author export, or its values are imputed (presence counted, per-sample detection not available). Counts as surface evidence.
- Held not counted 32 datasets
- The published table can't yet tell us which proteins were detected, for example conditions are pooled with no separable baseline. Listed, not counted.
- High background not counted 39 datasets
- Intact-cell labeling, but under the surface screen (25% of its length-corrected amount, or 20% of its list when no amounts are published, are Canonical or Likely Surfaceome proteins), so it is mostly intracellular contamination. Listed, not counted.
- Pre-filtered by surface annotation not counted 21 datasets
- The published table was already restricted to proteins annotated or predicted as surface or membrane proteins. Such a table cannot add a candidate or reveal a miss, and it would inflate the share of known surface proteins that the quality screen measures, so it is shown, cited only as support for proteins already in the reference, and never counted.
- Membrane fraction not counted 78 datasets
- Cells broken open and membranes purified, so it shows a protein is on a membrane (internal membranes included), not that it faces outward. Listed for comparison, not counted. One dataset here is instead an intact-cell label that reaches the inner side of the membrane, marked Inner-side labeling.
- Other condition not counted 86 datasets
- The same study's samples after a change of state, such as senescence, infection, a knockout, a drug or a disease. Each study counts only its baseline (untreated, wild-type or healthy) samples; this list shows what was detected in the other condition. Listed, not counted by default; the "Also count other conditions" switch counts it when the study's baseline dataset is counted.
Scores
- Surface overlap
- How much of a study is Canonical or Likely in our Surfaceome. A clean intact-cell experiment scores high; one swamped by intracellular contamination scores low. For datasets that report amounts (marked “amount”) it is the share of the length-corrected amount, and they need at least 25%; for the rest it is the share of proteins, and they need at least 20%, or count as Provisional within 2 points below it (light bar). The tick on each bar marks the bar that dataset had to reach.
- Counted datasets
- For a protein, how many of the 92 counted datasets detected it. Many independent detections on intact cells is strong evidence that the protein is surface-exposed in at least some cell types.
Surfaceome tier
- Canonical
- Our high-confidence surface shortlist: the deep dive found direct evidence that the protein sits on the cell surface and is reachable from outside.
- Likely
- Surface on broader evidence than Canonical: accessible, but with a caveat such as a mostly intracellular pool or surface display only in some cell states.
- Low confidence
- Below the Likely bar: the deep dive rated surface accessibility low or moderate, or the evidence is too thin for a shortlist.
- Uncertain
- The deep dive could not settle whether the protein reaches the surface.
- Not surface
- The deep dive judged the protein not accessible at the cell surface.
- Not deep-dived
- No deep-dive record: our triage step did not put this protein forward as a surface candidate, so it has no gene page.
- Consensus list: Every protein any of the 92 counted datasets detected, ranked by how many found it.
- New candidates: Detected on intact cells by at least 3 counted datasets, listed by at most one of the five surfaceome databases, and enriched over background (surface preference +10 or more). All three are adjustable.
- Possible misses: Detected by at least 3 counted datasets and enriched over background (surface preference +10 or more), but our deep dive rates them Low confidence, Uncertain or Not surface: a review list for our own calls.
Every dataset, one row per paper (expand a paper for its datasets), counted ones first. Tick one dataset to see its proteins, or several to see which proteins they share.
Each study counts only its baseline samples. The same studies' 86 other-condition datasets (senescent, infected, knockout, treated or diseased samples) are listed but not counted. Off by default. Each study counts only its baseline samples (untreated, wild-type or healthy cells). Switching this on also counts the same studies' other conditions, such as senescent, infected, knockout, drug-treated, differentiated or diseased samples, but only where the study's baseline dataset is itself counted: 37 of the 86 other-condition datasets qualify. Other conditions of held, high-background or comparator studies stay uncounted. The totals at the top of the Surface proteomics page are always baseline-only.
Choose datasets348 datasets from 228 papers · click to hide
A paper can contribute several datasets, for example one per cell line or labeling method. Faded rows are listed for completeness but not counted as surface evidence.
| Surface overlap: how much of a dataset is in the reference (Canonical or Likely in our Surfaceome catalog). When the published table reports per-protein amounts, it is the share of the dataset's total amount, each protein's amount divided by its length so the share counts molecules (marked “amount”), and the dataset needs at least 25% to count. Otherwise it is the share of the dataset's proteins, and it needs at least 20%, or a higher bar if the authors pre-filtered its list. The tick marks the bar. | Status says whether a dataset counts as surface evidence in the cross-study comparison.
| |||||||
|---|---|---|---|---|---|---|---|---|
Dual roles of host N-glycosylation in enteropathogenic Escherichia coli infection | 2026 | 2 datasets: 1 counted, 1 not counted | ||||||
Acute-leukemia surfaceome atlas Study list, tab “george-aml-2026”raw data not deposited | 2026 | Intact-cell labeling | Amine biotinylation | Cancer cell lines Blood cancers | 2,666 | 63%amount63% of this dataset's length-corrected protein amount is Canonical or Likely in our Surfaceome (30% of its proteins). Datasets whose table reports amounts need at least 25% of their amount (the tick). | CoreCore: intact-cell labeling that passes the surface screen: at least 25% of its length-corrected protein amount is Canonical or Likely Surfaceome proteins when the table reports amounts, otherwise at least 20% of its protein list. Counts as surface evidence. counted | |
Surface proteomics reveals arginine metabolism as a vulnerability in high grade serous ovarian cancer. | 2026 | 3 datasets: 3 counted | ||||||
Glyco-PDXplorer intact-cell CSC panel | 2026 | Intact-cell labeling | Glycopeptide capture | Squamous-carcinoma cell panel: Detroit, FaDU, KYSE70, MGH7, NOE, SCC25, SCC4, SCC42a and SCC8 Solid tumors | 833 | 97%amount97% of this dataset's length-corrected protein amount is Canonical or Likely in our Surfaceome (71% of its proteins). Datasets whose table reports amounts need at least 25% of their amount (the tick). | CoreCore: intact-cell labeling that passes the surface screen: at least 25% of its length-corrected protein amount is Canonical or Likely Surfaceome proteins when the table reports amounts, otherwise at least 20% of its protein list. Counts as surface evidence. counted | |
Comparative analysis of photocatalytic, enzymatic, and chemical approaches to identify canonical and noncanonical surfaceomes | 2026 | 8 datasets: 1 counted, 7 not counted | ||||||
Polarised colon epithelial apical/basolateral sulfo-NHS surfaceome Study list, tab “kuffa-crcpolar-2026”raw data not deposited | 2026 | Intact-cell labeling | Amine biotinylation | CRC cell lines (polarized) Solid tumors | 2,974 | 31%amount31% of this dataset's length-corrected protein amount is Canonical or Likely in our Surfaceome (17% of its proteins). Datasets whose table reports amounts need at least 25% of their amount (the tick). | CoreCore: intact-cell labeling that passes the surface screen: at least 25% of its length-corrected protein amount is Canonical or Likely Surfaceome proteins when the table reports amounts, otherwise at least 20% of its protein list. Counts as surface evidence. counted | |
Herpes simplex virus pUL56 abolishes neuronal activity by removing voltage-gated ion channels from the plasma membrane | 2026 | 3 datasets: 1 counted, 2 not counted | ||||||
C1s protects cutaneous squamous carcinoma cells from TRAIL-induced apoptosis | 2026 | 2 datasets: 1 counted, 1 not counted | ||||||
Jurkat sulfo-NHS-biotin surfaceome after dead-cell depletion | 2026 | Intact-cell labeling | Amine biotinylation | T-cell leukemia cell line Blood cancers | 1,543 | 64%amount64% of this dataset's length-corrected protein amount is Canonical or Likely in our Surfaceome (22% of its proteins). Datasets whose table reports amounts need at least 25% of their amount (the tick). | CoreCore: intact-cell labeling that passes the surface screen: at least 25% of its length-corrected protein amount is Canonical or Likely Surfaceome proteins when the table reports amounts, otherwise at least 20% of its protein list. Counts as surface evidence. counted | |
MPNST sulfo-NHS surfaceome, cell lines Study list, tab “stehn-mpnst-2026”raw data not deposited | 2026 | Intact-cell labeling | Amine biotinylation | MPNST cell lines Solid tumors | 2,674 | 79%amount79% of this dataset's length-corrected protein amount is Canonical or Likely in our Surfaceome (28% of its proteins). Datasets whose table reports amounts need at least 25% of their amount (the tick). | CoreCore: intact-cell labeling that passes the surface screen: at least 25% of its length-corrected protein amount is Canonical or Likely Surfaceome proteins when the table reports amounts, otherwise at least 20% of its protein list. Counts as surface evidence. counted | |
THP-1 macrophage intact-cell surface glycoproteome | 2026 | Intact-cell labeling | Glycopeptide capture | Monocytic leukemia line, macrophage-differentiated Blood cancers | 548 | 93%amount93% of this dataset's length-corrected protein amount is Canonical or Likely in our Surfaceome (80% of its proteins). Datasets whose table reports amounts need at least 25% of their amount (the tick). | CoreCore: intact-cell labeling that passes the surface screen: at least 25% of its length-corrected protein amount is Canonical or Likely Surfaceome proteins when the table reports amounts, otherwise at least 20% of its protein list. Counts as surface evidence. counted | |
Chronic ER Stress Triggers Cell-Surface Chaperones as the Therapeutic Targets of CAR Cells in Acute Myeloid Leukemia | 2026 | 4 datasets: 1 counted, 3 not counted | ||||||
Furan-biotin (MCF7) | 2025 | Intact-cell labeling | Other chemistryOther chemoproteomic labeling | MCF7 breast adenocarcinoma cells Solid tumors | 264 | 42%amount42% of this dataset's length-corrected protein amount is Canonical or Likely in our Surfaceome (55% of its proteins). Datasets whose table reports amounts need at least 25% of their amount (the tick). | CoreCore: intact-cell labeling that passes the surface screen: at least 25% of its length-corrected protein amount is Canonical or Likely Surfaceome proteins when the table reports amounts, otherwise at least 20% of its protein list. Counts as surface evidence. counted | |
HUVEC and dermal lymphatic endothelial sulfo-NHS-SS surfaceome with internalization Study list, tab “ito-huvec-hdlec-2025”raw data not deposited | 2025 | Intact-cell labeling | Amine biotinylation | Primary endothelial cells Other normal cells | 948 | 75%amount75% of this dataset's length-corrected protein amount is Canonical or Likely in our Surfaceome (44% of its proteins). Datasets whose table reports amounts need at least 25% of their amount (the tick). | CoreCore: intact-cell labeling that passes the surface screen: at least 25% of its length-corrected protein amount is Canonical or Likely Surfaceome proteins when the table reports amounts, otherwise at least 20% of its protein list. Counts as surface evidence. counted | |
LaccID CD8 T | 2025 | Intact-cell labeling | Proximity labelingPeroxidase or laccase proximity labeling | Primary T cells Immune cells | 1,605 | 38%amount38% of this dataset's length-corrected protein amount is Canonical or Likely in our Surfaceome (26% of its proteins). Datasets whose table reports amounts need at least 25% of their amount (the tick). | CoreCore: intact-cell labeling that passes the surface screen: at least 25% of its length-corrected protein amount is Canonical or Likely Surfaceome proteins when the table reports amounts, otherwise at least 20% of its protein list. Counts as surface evidence. counted | |
Exploitable mechanisms of antibody and CAR mediated macrophage cytotoxicity | 2025 | 2 datasets: 1 counted, 1 not counted | ||||||
Veneer microscale CSC | 2024 | Intact-cell labeling | Glycopeptide capture | B-cell glycocapture control experiment; untreated all-tier export Immune cells | 889 | 45%45% of this dataset's proteins are Canonical or Likely in our Surfaceome; datasets without published amounts need at least 20% of their proteins (the tick), or are Provisional within 2 points below it. | CoreCore: intact-cell labeling that passes the surface screen: at least 25% of its length-corrected protein amount is Canonical or Likely Surfaceome proteins when the table reports amounts, otherwise at least 20% of its protein list. Counts as surface evidence. counted | |
CD38 myeloma adapted CSC | 2024 | Intact-cell labeling | Glycoprotein capture | Multiple-myeloma lines AMO1, RPMI-8226 and K12/KMS-12 family Blood cancers | 3,098 | 38%amount38% of this dataset's length-corrected protein amount is Canonical or Likely in our Surfaceome (15% of its proteins). Datasets whose table reports amounts need at least 25% of their amount (the tick). | CoreCore: intact-cell labeling that passes the surface screen: at least 25% of its length-corrected protein amount is Canonical or Likely Surfaceome proteins when the table reports amounts, otherwise at least 20% of its protein list. Counts as surface evidence. counted | |
IRGQ-mediated autophagy in MHC class I quality control promotes tumor immune evasion | 2024 | 2 datasets: 1 counted, 1 not counted | ||||||
HFFF-TERT fibroblast plasma membrane profiling, control vs LMAN2L knockdown/knockout | 2024 | Intact-cell labeling | Glycoprotein capture | Immortalized primary fibroblasts Other normal cells | 1,535 | 65%amount65% of this dataset's length-corrected protein amount is Canonical or Likely in our Surfaceome (37% of its proteins). Datasets whose table reports amounts need at least 25% of their amount (the tick). | CoreCore: intact-cell labeling that passes the surface screen: at least 25% of its length-corrected protein amount is Canonical or Likely Surfaceome proteins when the table reports amounts, otherwise at least 20% of its protein list. Counts as surface evidence. counted | |
SLAPSHOT reveals rapid dynamics of extracellularly exposed proteome in response to calcium-activated plasma membrane phospholipid scrambling | 2024 | 2 datasets: 1 counted, 1 not counted | ||||||
Systematic Investigation of the Trafficking of Glycoproteins on the Cell Surface | 2024 | 7 datasets: 1 counted, 6 not counted | ||||||
sBioSITe PC-3 | 2023 | Intact-cell labeling | Amine biotinylation | PC-3 prostate cancer cells Solid tumors | 1,408 | 30%30% of this dataset's proteins are Canonical or Likely in our Surfaceome; datasets without published amounts need at least 20% of their proteins (the tick), or are Provisional within 2 points below it. | CoreCore: intact-cell labeling that passes the surface screen: at least 25% of its length-corrected protein amount is Canonical or Likely Surfaceome proteins when the table reports amounts, otherwise at least 20% of its protein list. Counts as surface evidence. counted | |
Peripheral blood mononuclear cell plasma membrane profiling, healthy vs COVID-19 | 2023 | Intact-cell labeling | Glycoprotein capture | Primary blood mononuclear cells Immune cells | 555 | 58%amount58% of this dataset's length-corrected protein amount is Canonical or Likely in our Surfaceome (48% of its proteins). Datasets whose table reports amounts need at least 25% of their amount (the tick). | CoreCore: intact-cell labeling that passes the surface screen: at least 25% of its length-corrected protein amount is Canonical or Likely Surfaceome proteins when the table reports amounts, otherwise at least 20% of its protein list. Counts as surface evidence. counted | |
A549, OVCAR3 and U87MG direct cell surface capture Study list, tab “tremblay-dcsc-2023”raw data not deposited | 2023 | Intact-cell labeling | Glycopeptide capture | Cancer cell lines Solid tumors | 730 | 89%amount89% of this dataset's length-corrected protein amount is Canonical or Likely in our Surfaceome (80% of its proteins). Datasets whose table reports amounts need at least 25% of their amount (the tick). | CoreCore: intact-cell labeling that passes the surface screen: at least 25% of its length-corrected protein amount is Canonical or Likely Surfaceome proteins when the table reports amounts, otherwise at least 20% of its protein list. Counts as surface evidence. counted | |
Patient-derived prostate cancer and BPH primary cells, sulfo-NHS-SS-biotin surfaceome | 2023 | Intact-cell labeling | Amine biotinylation | Patient-derived primary cells (prostate cancer and BPH) Solid tumors | 3,989 | 27%amount27% of this dataset's length-corrected protein amount is Canonical or Likely in our Surfaceome (13% of its proteins). Datasets whose table reports amounts need at least 25% of their amount (the tick). | CoreCore: intact-cell labeling that passes the surface screen: at least 25% of its length-corrected protein amount is Canonical or Likely Surfaceome proteins when the table reports amounts, otherwise at least 20% of its protein list. Counts as surface evidence. counted | |
Cys-Surf (Yan) Study list, tab “cyssurf-yan”PRIDE PXD042403: raw files | 2023 | Intact-cell labeling | Other chemistryOther chemoproteomic labeling | Jurkat T-cell leukemia cells; baseline cysteine-labeling list Blood cancers | 1,230 | 30%amount30% of this dataset's length-corrected protein amount is Canonical or Likely in our Surfaceome (24% of its proteins). Datasets whose table reports amounts need at least 25% of their amount (the tick). | CoreCore: intact-cell labeling that passes the surface screen: at least 25% of its length-corrected protein amount is Canonical or Likely Surfaceome proteins when the table reports amounts, otherwise at least 20% of its protein list. Counts as surface evidence. counted | |
SEMA4A myeloma PMP | 2022 | Intact-cell labeling | Glycoprotein capture | Multiple-myeloma cell lines and primary CD138+ patient plasma cells Blood cancers | 5,027 | 33%amount33% of this dataset's length-corrected protein amount is Canonical or Likely in our Surfaceome (20% of its proteins). Datasets whose table reports amounts need at least 25% of their amount (the tick). | CoreCore: intact-cell labeling that passes the surface screen: at least 25% of its length-corrected protein amount is Canonical or Likely Surfaceome proteins when the table reports amounts, otherwise at least 20% of its protein list. Counts as surface evidence. counted | |
Spatial proteomics finds CD155 and Endophilin-A1 as mediators of growth and invasion in medulloblastoma | 2022 | 4 datasets: 1 counted, 3 not counted | ||||||
Selective modulation of cell surface proteins during vaccinia infection: A resource for identifying viral immune evasion strategies | 2022 | 4 datasets: 1 counted, 3 not counted | ||||||
Myeloma adapted CSC | 2022 | Intact-cell labeling | Glycoprotein capture | Four baseline multiple-myeloma cell lines; patient extensions not yet integrated Blood cancers | 1,136 | 72%amount72% of this dataset's length-corrected protein amount is Canonical or Likely in our Surfaceome (44% of its proteins). Datasets whose table reports amounts need at least 25% of their amount (the tick). | CoreCore: intact-cell labeling that passes the surface screen: at least 25% of its length-corrected protein amount is Canonical or Likely Surfaceome proteins when the table reports amounts, otherwise at least 20% of its protein list. Counts as surface evidence. counted | |
A549-ACE2-TMPRSS2 plasma membrane profiling, mock vs SARS-CoV-2 | 2022 | Intact-cell labeling | Glycoprotein capture | Engineered lung adenocarcinoma cell line Solid tumors | 4,930 | 46%amount46% of this dataset's length-corrected protein amount is Canonical or Likely in our Surfaceome (15% of its proteins). Datasets whose table reports amounts need at least 25% of their amount (the tick). | CoreCore: intact-cell labeling that passes the surface screen: at least 25% of its length-corrected protein amount is Canonical or Likely Surfaceome proteins when the table reports amounts, otherwise at least 20% of its protein list. Counts as surface evidence. counted | |
SH-SY5Y neuroblastoma sulfo-NHS surfaceome with no-biotin control Study list, tab “gangras-shsy5y-2022”raw data not deposited | 2022 | Intact-cell labeling | Amine biotinylation | Neuroblastoma cell line Solid tumors | 885 | 31%amount31% of this dataset's length-corrected protein amount is Canonical or Likely in our Surfaceome (35% of its proteins). Datasets whose table reports amounts need at least 25% of their amount (the tick). | CoreCore: intact-cell labeling that passes the surface screen: at least 25% of its length-corrected protein amount is Canonical or Likely Surfaceome proteins when the table reports amounts, otherwise at least 20% of its protein list. Counts as surface evidence. counted | |
RWPE-1 WGA-HRP/APEX | 2022 | Intact-cell labeling | Proximity labelingPeroxidase or laccase proximity labeling | RWPE-1 prostate epithelial empty-vector intact cells; excludes exosome and MYC arms Other normal cells | 1,320 | 34%34% of this dataset's proteins are Canonical or Likely in our Surfaceome; datasets without published amounts need at least 20% of their proteins (the tick), or are Provisional within 2 points below it. | CoreCore: intact-cell labeling that passes the surface screen: at least 25% of its length-corrected protein amount is Canonical or Likely Surfaceome proteins when the table reports amounts, otherwise at least 20% of its protein list. Counts as surface evidence. counted | |
HL60 sulfo-NHS-SS-biotin labeled-peptide surfaceome | 2022 | Intact-cell labeling | Amine biotinylation | Acute myeloid leukemia cell line Blood cancers | 414 | 39%39% of this dataset's proteins are Canonical or Likely in our Surfaceome; datasets without published amounts need at least 20% of their proteins (the tick), or are Provisional within 2 points below it. | CoreCore: intact-cell labeling that passes the surface screen: at least 25% of its length-corrected protein amount is Canonical or Likely Surfaceome proteins when the table reports amounts, otherwise at least 20% of its protein list. Counts as surface evidence. counted | |
HeLa sulfo-NHS-biotin labeled-peptide surfaceome, Tamavidin 2-REV, TMT11 EGF time course | 2022 | Intact-cell labeling | Amine biotinylation | Cancer cell line Solid tumors | 1,792 | 34%amount34% of this dataset's length-corrected protein amount is Canonical or Likely in our Surfaceome (20% of its proteins). Datasets whose table reports amounts need at least 25% of their amount (the tick). | CoreCore: intact-cell labeling that passes the surface screen: at least 25% of its length-corrected protein amount is Canonical or Likely Surfaceome proteins when the table reports amounts, otherwise at least 20% of its protein list. Counts as surface evidence. counted | |
HAP1 (DAG1-null) ST6GAL1 exo-enzymatic biotin-sialic acid labeling | 2022 | Intact-cell labeling | Glycoprotein capture | Leukemia-derived haploid cell line (genetically modified) Blood cancers | 227 | 43%amount43% of this dataset's length-corrected protein amount is Canonical or Likely in our Surfaceome (38% of its proteins). Datasets whose table reports amounts need at least 25% of their amount (the tick). | CoreCore: intact-cell labeling that passes the surface screen: at least 25% of its length-corrected protein amount is Canonical or Likely Surfaceome proteins when the table reports amounts, otherwise at least 20% of its protein list. Counts as surface evidence. counted | |
HeLa 1-min peroxidase-mediated (PECSL) surface biotinylation with negative control | 2021 | Intact-cell labeling | Proximity labelingPeroxidase or laccase proximity labeling | Cancer cell line Solid tumors | 2,314 | 34%amount34% of this dataset's length-corrected protein amount is Canonical or Likely in our Surfaceome (18% of its proteins). Datasets whose table reports amounts need at least 25% of their amount (the tick). | CoreCore: intact-cell labeling that passes the surface screen: at least 25% of its length-corrected protein amount is Canonical or Likely Surfaceome proteins when the table reports amounts, otherwise at least 20% of its protein list. Counts as surface evidence. counted | |
Glioblastoma lines and astrocyte sulfo-NHS-SS-biotin surfaceome with no-biotin controls | 2021 | Intact-cell labeling | Amine biotinylation | Glioblastoma cell lines and astrocyte line Solid tumors | 1,631 | 33%amount33% of this dataset's length-corrected protein amount is Canonical or Likely in our Surfaceome (17% of its proteins). Datasets whose table reports amounts need at least 25% of their amount (the tick). | CoreCore: intact-cell labeling that passes the surface screen: at least 25% of its length-corrected protein amount is Canonical or Likely Surfaceome proteins when the table reports amounts, otherwise at least 20% of its protein list. Counts as surface evidence. counted | |
Immune IFN PMP Study list, tab “soday-2021”PRIDE PXD022834: raw files | 2021 | Intact-cell labeling | Glycoprotein capture | Primary CD14+ monocytes and CD4+ T cells from leukapheresis/PBMC donors Immune cells | 1,229 | 47%amount47% of this dataset's length-corrected protein amount is Canonical or Likely in our Surfaceome (35% of its proteins). Datasets whose table reports amounts need at least 25% of their amount (the tick). | CoreCore: intact-cell labeling that passes the surface screen: at least 25% of its length-corrected protein amount is Canonical or Likely Surfaceome proteins when the table reports amounts, otherwise at least 20% of its protein list. Counts as surface evidence. counted | |
HeLa periodate/aminooxy-biotin SILAC surfaceome, mock vs AP-2 mu2 knockdown Study list, tab “tobys-hela-ap2-2021”PRIDE PXD014925: raw files, not yet released | 2021 | Intact-cell labeling | Glycoprotein capture | Cervical adenocarcinoma cell line Solid tumors | 2,310 | 66%amount66% of this dataset's length-corrected protein amount is Canonical or Likely in our Surfaceome (23% of its proteins). Datasets whose table reports amounts need at least 25% of their amount (the tick). | CoreCore: intact-cell labeling that passes the surface screen: at least 25% of its length-corrected protein amount is Canonical or Likely Surfaceome proteins when the table reports amounts, otherwise at least 20% of its protein list. Counts as surface evidence. counted | |
Primary monocyte-derived macrophage and U87MG sulfo-NHS-LC-biotin surface peptidome | 2020 | Intact-cell labeling | Amine biotinylation | Primary macrophages; glioblastoma cell line Immune cells | 1,096 | 54%amount54% of this dataset's length-corrected protein amount is Canonical or Likely in our Surfaceome (39% of its proteins). Datasets whose table reports amounts need at least 25% of their amount (the tick). | CoreCore: intact-cell labeling that passes the surface screen: at least 25% of its length-corrected protein amount is Canonical or Likely Surfaceome proteins when the table reports amounts, otherwise at least 20% of its protein list. Counts as surface evidence. counted | |
HL60 sulfo-NHS-SS-biotin labeled-peptide surfaceome with and without partial surface proteolysis Study list, tab “lango-hl60-proteolysis-2020”raw data not deposited | 2020 | Intact-cell labeling | Amine biotinylation | Cancer cell line Blood cancers | 61 | 61%amount61% of this dataset's length-corrected protein amount is Canonical or Likely in our Surfaceome (74% of its proteins). Datasets whose table reports amounts need at least 25% of their amount (the tick). | CoreCore: intact-cell labeling that passes the surface screen: at least 25% of its length-corrected protein amount is Canonical or Likely Surfaceome proteins when the table reports amounts, otherwise at least 20% of its protein list. Counts as surface evidence. counted | |
Myeloma CSC resource | 2020 | Intact-cell labeling | Glycopeptide capture | MM.1R, RPMI-8226, RPMI-8226/R5 and U266 myeloma lines; RPMI-1788 and BLCL B-cell controls Blood cancers | 676 | 69%amount69% of this dataset's length-corrected protein amount is Canonical or Likely in our Surfaceome (52% of its proteins). Datasets whose table reports amounts need at least 25% of their amount (the tick). | CoreCore: intact-cell labeling that passes the surface screen: at least 25% of its length-corrected protein amount is Canonical or Likely Surfaceome proteins when the table reports amounts, otherwise at least 20% of its protein list. Counts as surface evidence. counted | |
Temporal Proteomic Analysis of Herpes Simplex Virus 1 Infection Reveals Cell-Surface Remodeling via pUL56-Mediated GOPC Degradation | 2020 | 2 datasets: 2 counted | ||||||
Naive/primed PMP | 2020 | Intact-cell labeling | Glycoprotein capture | Primed human pluripotent stem cells; two culture replicates across two media Stem & stromal | 5,865 | 34%amount34% of this dataset's length-corrected protein amount is Canonical or Likely in our Surfaceome (16% of its proteins). Datasets whose table reports amounts need at least 25% of their amount (the tick). | CoreCore: intact-cell labeling that passes the surface screen: at least 25% of its length-corrected protein amount is Canonical or Likely Surfaceome proteins when the table reports amounts, otherwise at least 20% of its protein list. Counts as surface evidence. counted | |
B-cell line plasma membrane profiling, periodate/aminooxy-biotin (Zurli et al. 2020 deposit) | 2020 | Intact-cell labeling | Glycoprotein capture | B-cell lymphoma/leukemia lines and EBV-transformed B cells Blood cancers | 1,203 | 99%amount99% of this dataset's length-corrected protein amount is Canonical or Likely in our Surfaceome (49% of its proteins). Datasets whose table reports amounts need at least 25% of their amount (the tick). | CoreCore: intact-cell labeling that passes the surface screen: at least 25% of its length-corrected protein amount is Canonical or Likely Surfaceome proteins when the table reports amounts, otherwise at least 20% of its protein list. Counts as surface evidence. counted | |
Primary erythrocyte plasma membrane profiling, UK and Senegalese donors | 2019 | Intact-cell labeling | Glycoprotein capture | Primary erythrocytes Other normal cells | 1,245 | 39%amount39% of this dataset's length-corrected protein amount is Canonical or Likely in our Surfaceome (19% of its proteins). Datasets whose table reports amounts need at least 25% of their amount (the tick). | CoreCore: intact-cell labeling that passes the surface screen: at least 25% of its length-corrected protein amount is Canonical or Likely Surfaceome proteins when the table reports amounts, otherwise at least 20% of its protein list. Counts as surface evidence. counted | |
Eight human cell lines, GalNAz metabolic labeling + DBCO-biotin click surface N-glycoproteomics Study list, tab “suttapitugsakul-8lines-2019”raw data not deposited | 2019 | Intact-cell labeling | Glycopeptide capture | Cancer and immortalized cell lines (eight) Multi-cell-type atlases | 1,031 | 61%61% of this dataset's proteins are Canonical or Likely in our Surfaceome; datasets without published amounts need at least 20% of their proteins (the tick), or are Provisional within 2 points below it. | CoreCore: intact-cell labeling that passes the surface screen: at least 25% of its length-corrected protein amount is Canonical or Likely Surfaceome proteins when the table reports amounts, otherwise at least 20% of its protein list. Counts as surface evidence. counted | |
autoCSC | 2019 | Intact-cell labeling | Glycopeptide capture | 11 cell lines: A549, HBE, A431, Caco-2, HEK293, HeLa, HT29, HepG2, Huh7, MDA-MB-231 and U87 Multi-cell-type atlases | 884 | 77%77% of this dataset's proteins are Canonical or Likely in our Surfaceome; datasets without published amounts need at least 20% of their proteins (the tick), or are Provisional within 2 points below it. | CoreCore: intact-cell labeling that passes the surface screen: at least 25% of its length-corrected protein amount is Canonical or Likely Surfaceome proteins when the table reports amounts, otherwise at least 20% of its protein list. Counts as surface evidence. counted | |
Epstein-Barr-Virus-Induced One-Carbon Metabolism Drives B Cell Transformation | 2019 | 2 datasets: 1 counted, 1 not counted | ||||||
HeLa plasma membrane profiling, uninfected vs EHEC, spike-in SILAC | 2018 | Intact-cell labeling | Glycoprotein capture | Cervical cancer cell line Solid tumors | 959 | 37%37% of this dataset's proteins are Canonical or Likely in our Surfaceome; datasets without published amounts need at least 20% of their proteins (the tick), or are Provisional within 2 points below it. | CoreCore: intact-cell labeling that passes the surface screen: at least 25% of its length-corrected protein amount is Canonical or Likely Surfaceome proteins when the table reports amounts, otherwise at least 20% of its protein list. Counts as surface evidence. counted | |
The NAD(+) Salvage Pathway Supports PHGDH-Driven Serine Biosynthesis | 2018 | 2 datasets: 1 counted, 1 not counted | ||||||
P3HR1 Burkitt lymphoma plasma membrane profiling, uninduced vs EBV lytic | 2017 | Intact-cell labeling | Glycoprotein capture | Burkitt lymphoma cell line Blood cancers | 1,000 | 55%amount55% of this dataset's length-corrected protein amount is Canonical or Likely in our Surfaceome (30% of its proteins). Datasets whose table reports amounts need at least 25% of their amount (the tick). | CoreCore: intact-cell labeling that passes the surface screen: at least 25% of its length-corrected protein amount is Canonical or Likely Surfaceome proteins when the table reports amounts, otherwise at least 20% of its protein list. Counts as surface evidence. counted | |
Control of immune ligands by members of a cytomegalovirus gene expansion suppresses natural killer cell activation | 2017 | 3 datasets: 1 counted, 2 not counted | ||||||
Lymphoid CSC Study list, tab “haverland-2017”raw data not deposited | 2017 | Intact-cell labeling | Glycopeptide capture | Lymphoid lines HG3, Ramos, RCH-ACV and Jurkat Blood cancers | 390 | 74%74% of this dataset's proteins are Canonical or Likely in our Surfaceome; datasets without published amounts need at least 20% of their proteins (the tick), or are Provisional within 2 points below it. | CoreCore: intact-cell labeling that passes the surface screen: at least 25% of its length-corrected protein amount is Canonical or Likely Surfaceome proteins when the table reports amounts, otherwise at least 20% of its protein list. Counts as surface evidence. counted | |
K562 and HL60 labeled extracellular lysine peptides, sulfo-NHS-SS-biotin Study list, tab “lango-leukemia-2017”raw data not deposited | 2017 | Intact-cell labeling | Amine biotinylation | Leukemia cell lines Blood cancers | 360 | 38%38% of this dataset's proteins are Canonical or Likely in our Surfaceome; datasets without published amounts need at least 20% of their proteins (the tick), or are Provisional within 2 points below it. | CoreCore: intact-cell labeling that passes the surface screen: at least 25% of its length-corrected protein amount is Canonical or Likely Surfaceome proteins when the table reports amounts, otherwise at least 20% of its protein list. Counts as surface evidence. counted | |
Hepatic endoderm CSC Study list, tab “hepatic-endoderm-2017”raw data not deposited | 2017 | Intact-cell labeling | Glycopeptide capture | iPSC-derived hepatic endoderm Stem & stromal | 395 | 84%84% of this dataset's proteins are Canonical or Likely in our Surfaceome; datasets without published amounts need at least 20% of their proteins (the tick), or are Provisional within 2 points below it. | CoreCore: intact-cell labeling that passes the surface screen: at least 25% of its length-corrected protein amount is Canonical or Likely Surfaceome proteins when the table reports amounts, otherwise at least 20% of its protein list. Counts as surface evidence. counted | |
Human atrial stromal cell sulfo-NHS-SS-biotin surfaceome | 2017 | Intact-cell labeling | Amine biotinylation | Primary cardiac stromal cells Stem & stromal | 810 | 28%28% of this dataset's proteins are Canonical or Likely in our Surfaceome; datasets without published amounts need at least 20% of their proteins (the tick), or are Provisional within 2 points below it. | CoreCore: intact-cell labeling that passes the surface screen: at least 25% of its length-corrected protein amount is Canonical or Likely Surfaceome proteins when the table reports amounts, otherwise at least 20% of its protein list. Counts as surface evidence. counted | |
IMR90 fibroblast plasma membrane profiling, growing vs HRAS-G12V senescent, SILAC | 2016 | Intact-cell labeling | Glycoprotein capture | Normal diploid fibroblast line (engineered) Other normal cells | 591 | 93%amount93% of this dataset's length-corrected protein amount is Canonical or Likely in our Surfaceome (57% of its proteins). Datasets whose table reports amounts need at least 25% of their amount (the tick). | CoreCore: intact-cell labeling that passes the surface screen: at least 25% of its length-corrected protein amount is Canonical or Likely Surfaceome proteins when the table reports amounts, otherwise at least 20% of its protein list. Counts as surface evidence. counted | |
Primary hepatocyte CSC Study list, tab “mallanna-2016”raw data not deposited | 2016 | Intact-cell labeling | Glycopeptide capture | Primary hepatocytes Other normal cells | 300 | 66%66% of this dataset's proteins are Canonical or Likely in our Surfaceome; datasets without published amounts need at least 20% of their proteins (the tick), or are Provisional within 2 points below it. | CoreCore: intact-cell labeling that passes the surface screen: at least 25% of its length-corrected protein amount is Canonical or Likely Surfaceome proteins when the table reports amounts, otherwise at least 20% of its protein list. Counts as surface evidence. counted | |
One-Step Selective Exoenzymatic Labeling (SEEL) Strategy for the Biotinylation and Identification of Glycoproteins of Living Cells | 2016 | 2 datasets: 2 counted | ||||||
Site-Specific Quantification of Surface N-Glycoproteins in Statin-Treated Liver Cells | 2016 | 3 datasets: 3 counted | ||||||
Comparative proteomics of a model MCF10A-KRasG12V cell line reveals a distinct molecular signature of the KRasG12V cell surface | 2016 | 4 datasets: 1 counted, 3 not counted | ||||||
CSPA Study list, tab “cspa-2015”PRIDE PXD000589: processed files only, no raw files | 2015 | Intact-cell labeling | Glycopeptide capture | Multi-cell-type human atlas: 47 human cell-type/sample summaries, Table B Multi-cell-type atlases | 1,444 | 62%62% of this dataset's proteins are Canonical or Likely in our Surfaceome; datasets without published amounts need at least 20% of their proteins (the tick), or are Provisional within 2 points below it. | CoreCore: intact-cell labeling that passes the surface screen: at least 25% of its length-corrected protein amount is Canonical or Likely Surfaceome proteins when the table reports amounts, otherwise at least 20% of its protein list. Counts as surface evidence. counted | |
Systematic and site-specific analysis of N-sialoglycosylated proteins on the cell surface by integrating click chemistry and MS-based proteomics | 2015 | 2 datasets: 2 counted | ||||||
Primary hepatocyte, lung fibroblast, airway epithelium, A549 and HepG2 hydrazide CSC with no-biocytin controls | 2015 | Intact-cell labeling | Glycopeptide capture | Primary hepatocytes, primary lung cells and cell lines Multi-cell-type atlases | 535 | 53%53% of this dataset's proteins are Canonical or Likely in our Surfaceome; datasets without published amounts need at least 20% of their proteins (the tick), or are Provisional within 2 points below it. | CoreCore: intact-cell labeling that passes the surface screen: at least 25% of its length-corrected protein amount is Canonical or Likely Surfaceome proteins when the table reports amounts, otherwise at least 20% of its protein list. Counts as surface evidence. counted | |
A Combined Omics Approach to Generate the Surface Atlas of Human Naive CD4+ T Cells during Early T-Cell Receptor Activation | 2015 | 11 datasets: 1 counted, 10 not counted | ||||||
Carbonic anhydrase XII is a new therapeutic target to overcome chemoresistance in cancer cells | 2015 | 2 datasets: 1 counted, 1 not counted | ||||||
CEM-T4 T-cell plasma membrane profiling, HIV-1 time course | 2015 | Intact-cell labeling | Glycoprotein capture | T-cell leukemia line Blood cancers | 2,183 | 48%amount48% of this dataset's length-corrected protein amount is Canonical or Likely in our Surfaceome (23% of its proteins). Datasets whose table reports amounts need at least 25% of their amount (the tick). | CoreCore: intact-cell labeling that passes the surface screen: at least 25% of its length-corrected protein amount is Canonical or Likely Surfaceome proteins when the table reports amounts, otherwise at least 20% of its protein list. Counts as surface evidence. counted | |
Quantitative comparison of a human cancer cell surface proteome between interphase and mitosis | 2015 | 2 datasets: 1 counted, 1 not counted | ||||||
HEK293T metabolic GalNAz click surface N-glycosites Study list, tab “smeekens-hek293t-galnaz-2015”raw data not deposited | 2015 | Intact-cell labeling | Glycopeptide capture | Embryonic kidney cell line Other normal cells | 110 | 71%71% of this dataset's proteins are Canonical or Likely in our Surfaceome; datasets without published amounts need at least 20% of their proteins (the tick), or are Provisional within 2 points below it. | CoreCore: intact-cell labeling that passes the surface screen: at least 25% of its length-corrected protein amount is Canonical or Likely Surfaceome proteins when the table reports amounts, otherwise at least 20% of its protein list. Counts as surface evidence. counted | |
Primary GBM cultures, astrocytes and NPCs, metabolic-azide surface sialoglycoproteome Study list, tab “autelitano-gbm-sialo-2014”raw data not deposited | 2014 | Intact-cell labeling | Glycoprotein capture | Primary glioblastoma cultures and primary neural cells Solid tumors | 838 | 66%amount66% of this dataset's length-corrected protein amount is Canonical or Likely in our Surfaceome (67% of its proteins). Datasets whose table reports amounts need at least 25% of their amount (the tick). | CoreCore: intact-cell labeling that passes the surface screen: at least 25% of its length-corrected protein amount is Canonical or Likely Surfaceome proteins when the table reports amounts, otherwise at least 20% of its protein list. Counts as surface evidence. counted | |
hPSC surface map Study list, tab “boheler-2014”raw data not deposited | 2014 | Intact-cell labeling | Glycopeptide capture | Embryonic and induced pluripotent stem cells (hESC/iPSC) Stem & stromal | 496 | 84%84% of this dataset's proteins are Canonical or Likely in our Surfaceome; datasets without published amounts need at least 20% of their proteins (the tick), or are Provisional within 2 points below it. | CoreCore: intact-cell labeling that passes the surface screen: at least 25% of its length-corrected protein amount is Canonical or Likely Surfaceome proteins when the table reports amounts, otherwise at least 20% of its protein list. Counts as surface evidence. counted | |
Quantitative temporal viromics: an approach to investigate host-pathogen interaction | 2014 | 3 datasets: 1 counted, 2 not counted | ||||||
Osteosarcoma and osteoblast sulfo-NHS surfaceome Study list, tab “posthumadeboer-os-2013”raw data not deposited | 2013 | Intact-cell labeling | Amine biotinylation | Osteosarcoma cell lines and primary osteoblasts Solid tumors | 2,740 | 29%amount29% of this dataset's length-corrected protein amount is Canonical or Likely in our Surfaceome (19% of its proteins). Datasets whose table reports amounts need at least 25% of their amount (the tick). | CoreCore: intact-cell labeling that passes the surface screen: at least 25% of its length-corrected protein amount is Canonical or Likely Surfaceome proteins when the table reports amounts, otherwise at least 20% of its protein list. Counts as surface evidence. counted | |
Glycoproteomics enabled by tagging sialic acid- or galactose-terminated glycans | 2013 | 2 datasets: 2 counted | ||||||
THP-1 monocytic cell plasma membrane profiling, vector vs HCMV UL138 SILAC Study list, tab “weekes-thp1-ul138-2013”raw data not deposited | 2013 | Intact-cell labeling | Glycoprotein capture | Monocytic leukemia cell line Blood cancers | 612 | 69%69% of this dataset's proteins are Canonical or Likely in our Surfaceome; datasets without published amounts need at least 20% of their proteins (the tick), or are Provisional within 2 points below it. | CoreCore: intact-cell labeling that passes the surface screen: at least 25% of its length-corrected protein amount is Canonical or Likely Surfaceome proteins when the table reports amounts, otherwise at least 20% of its protein list. Counts as surface evidence. counted | |
MDA-MB-435 isogenic metastatic/non-metastatic sublines, sulfo-NHS-SS-biotin surfaceome Study list, tab “karhemo-mda435-2012”raw data not deposited | 2012 | Intact-cell labeling | Amine biotinylation | Cancer cell line (MDA-MB-435) Solid tumors | 61 | 93%amount93% of this dataset's length-corrected protein amount is Canonical or Likely in our Surfaceome (75% of its proteins). Datasets whose table reports amounts need at least 25% of their amount (the tick). | CoreCore: intact-cell labeling that passes the surface screen: at least 25% of its length-corrected protein amount is Canonical or Likely Surfaceome proteins when the table reports amounts, otherwise at least 20% of its protein list. Counts as surface evidence. counted | |
Surfaceome Capture by Multiplex Biotinylation Enables Enhanced Identification of Cell Surface Proteins by Mass Spectrometry | 2026 | 4 datasets: 1 counted, 3 not counted | ||||||
GASF recovered probe-bearing human peptides | 2024 | Intact-cell labeling | Other chemistryOther chemoproteomic labeling | HeLa cervical adenocarcinoma cells Solid tumors | 1,354 | 22%22% of this dataset's proteins are Canonical or Likely in our Surfaceome; datasets without published amounts need at least 20% of their proteins (the tick), or are Provisional within 2 points below it. | ProvisionalProvisional: intact-cell labeling that passes with a caveat: it sits within 2 points below the 20% list screen (18–20%), it has no no-label control, it was built from a partial author export, or its values are imputed (presence counted, per-sample detection not available). Counts as surface evidence. counted built from a partial author export (peptide-level table) | |
DIPG periodate/aminooxy-biotin surfaceome | 2023 | Intact-cell labeling | Glycoprotein capture | Patient-derived DIPG cell lines Solid tumors | 2,956 | 34%34% of this dataset's proteins are Canonical or Likely in our Surfaceome; datasets without published amounts need at least 20% of their proteins (the tick), or are Provisional within 2 points below it. | ProvisionalProvisional: intact-cell labeling that passes with a caveat: it sits within 2 points below the 20% list screen (18–20%), it has no no-label control, it was built from a partial author export, or its values are imputed (presence counted, per-sample detection not available). Counts as surface evidence. counted values are imputed: presence counted, per-sample detection not available | |
B-ALL CD72 CSC | 2021 | Intact-cell labeling | Glycoprotein capture | B-cell acute lymphoblastic leukemia cell-line panel Blood cancers | 3,783 | 20%20% of this dataset's proteins are Canonical or Likely in our Surfaceome; datasets without published amounts need at least 20% of their proteins (the tick), or are Provisional within 2 points below it. | ProvisionalProvisional: intact-cell labeling that passes with a caveat: it sits within 2 points below the 20% list screen (18–20%), it has no no-label control, it was built from a partial author export, or its values are imputed (presence counted, per-sample detection not available). Counts as surface evidence. counted within 2 points of the 20% screen (19.7%) | |
Human lung cancer cell line biotin-directed affinity purification of integral plasma-membrane proteins Study list, tab “zhao-lung-bdap-2004”raw data not deposited | 2004 | Intact-cell labeling | Amine biotinylation | Lung cancer cell line Solid tumors | 644 | 20%20% of this dataset's proteins are Canonical or Likely in our Surfaceome; datasets without published amounts need at least 20% of their proteins (the tick), or are Provisional within 2 points below it. | ProvisionalProvisional: intact-cell labeling that passes with a caveat: it sits within 2 points below the 20% list screen (18–20%), it has no no-label control, it was built from a partial author export, or its values are imputed (presence counted, per-sample detection not available). Counts as surface evidence. counted within 2 points of the 20% screen (19.9%) | |
T128 uveal melanoma periodate/aminooxy-biotin surfaceome, RAB1A-manipulated and control lines pooled | 2026 | Intact-cell labeling | Glycoprotein capture | Uveal melanoma cell line Solid tumors | 3,526 | 16%16% of this dataset's proteins are Canonical or Likely in our Surfaceome; datasets without published amounts need at least 20% of their proteins (the tick), or are Provisional within 2 points below it. | HeldHeld: the published table can't yet tell us which proteins were detected, for example conditions are pooled with no separable baseline. Listed, not counted. not counted conditions are pooled in one list, with no separable baseline | |
Analysis of stress-induced surfaceome remodeling reveals surface accumulation of the cation-independent mannose-6-phosphate receptor (CI-M6PR) | 2026 | 3 datasets: 0 counted, 3 not counted | ||||||
HCT116 exogenous APEX2 surface proximity labeling | 2026 | Intact-cell labeling | Proximity labelingPeroxidase or laccase proximity labeling | CRC cell line Solid tumors | 656 | 13%13% of this dataset's proteins are Canonical or Likely in our Surfaceome; datasets without published amounts need at least 20% of their proteins (the tick), or are Provisional within 2 points below it. | HeldHeld: the published table can't yet tell us which proteins were detected, for example conditions are pooled with no separable baseline. Listed, not counted. not counted no background control in the deposit | |
Quantitative Mass Spectrometry-Based Profiling of Cell Surface and Crude Membrane Proteins in Cisplatin-Resistant Triple-Negative Breast Cancer (jPOST JPST003825; no publication) | 2026 | 4 datasets: 0 counted, 4 not counted | ||||||
Sensory-neuron surfaceome Study list, tab “breyer-2025”raw data not deposited | 2025 | Intact-cell labeling | Amine biotinylation | iPSC-derived sensory-like neurons; Fabry and control donors Neural cells | 1,371 | 33%33% of this dataset's proteins are Canonical or Likely in our Surfaceome; datasets without published amounts need at least 20% of their proteins (the tick), or are Provisional within 2 points below it. | HeldHeld: the published table can't yet tell us which proteins were detected, for example conditions are pooled with no separable baseline. Listed, not counted. not counted conditions are pooled in one list, with no separable baseline | |
IFITM1 as a modulator of surfaceome dynamics and aggressive phenotype in cervical cancer cells | 2025 | 3 datasets: 0 counted, 3 not counted | ||||||
i3Neuron GM2 gangliosidosis models, plasma-membrane profiling | 2025 | Intact-cell labeling | Glycoprotein capture | iPSC-derived neurons Neural cells | 2,716 | 27%27% of this dataset's proteins are Canonical or Likely in our Surfaceome; datasets without published amounts need at least 20% of their proteins (the tick), or are Provisional within 2 points below it. | HeldHeld: the published table can't yet tell us which proteins were detected, for example conditions are pooled with no separable baseline. Listed, not counted. not counted the sample-to-condition map is unpublished | |
LASA AML atlas Study list, tab “lasa-2024”PRIDE PXD043772: raw files | 2024 | Intact-cell labeling | Amine biotinylation | Primary AML specimens, Leucegene cohort (100 specimens); baseline mapping unresolved Blood cancers | 3,053 | 16%16% of this dataset's proteins are Canonical or Likely in our Surfaceome; datasets without published amounts need at least 20% of their proteins (the tick), or are Provisional within 2 points below it. | HeldHeld: the published table can't yet tell us which proteins were detected, for example conditions are pooled with no separable baseline. Listed, not counted. not counted the input sample and baseline can't be identified in the published table | |
Cell membrane proteome analysis in HEK293T cells challenged with α-synuclein amyloids | 2024 | 4 datasets: 0 counted, 4 not counted | ||||||
Chondrosarcoma SUSPECS surfaceome | 2023 | Intact-cell labeling | Glycoprotein capture | Chondrosarcoma cell line Solid tumors | 814 | 51%51% of this dataset's proteins are Canonical or Likely in our Surfaceome; datasets without published amounts need at least 20% of their proteins (the tick), or are Provisional within 2 points below it. | HeldHeld: the published table can't yet tell us which proteins were detected, for example conditions are pooled with no separable baseline. Listed, not counted. not counted conditions are pooled in one list, with no separable baseline | |
T-cell surface proteome Study list, tab “byrnes-2022”PRIDE PXD024789: raw files | 2022 | Intact-cell labeling | Glycopeptide capture | Primary T-cell populations including CD8+ effectors and regulatory T cells; activation/hypoxia/coculture comparisons Immune cells | 1,230 | 49%49% of this dataset's proteins are Canonical or Likely in our Surfaceome; datasets without published amounts need at least 20% of their proteins (the tick), or are Provisional within 2 points below it. | HeldHeld: the published table can't yet tell us which proteins were detected, for example conditions are pooled with no separable baseline. Listed, not counted. not counted conditions are pooled in one list, with no separable baseline | |
Mapping the cell-membrane proteome of the SKBR3/HER2+ cell line to the cancer hallmarks | 2022 | 3 datasets: 0 counted, 3 not counted | ||||||
MYC surfaceome | 2021 | Intact-cell labeling | Glycopeptide capture | P493-6 B cells and RWPE-1/PrEC-LHS prostate cells; mixed MYC conditions Other normal cells | 1,229 | 48%48% of this dataset's proteins are Canonical or Likely in our Surfaceome; datasets without published amounts need at least 20% of their proteins (the tick), or are Provisional within 2 points below it. | HeldHeld: the published table can't yet tell us which proteins were detected, for example conditions are pooled with no separable baseline. Listed, not counted. not counted conditions are pooled in one list, with no separable baseline | |
Surface AMP deaminase 2 as a novel regulator modifying extracellular adenine nucleotide metabolism | 2021 | 2 datasets: 0 counted, 2 not counted | ||||||
The IMiD target CRBN determines HSP90 activity toward transmembrane proteins essential in multiple myeloma | 2021 | 2 datasets: 0 counted, 2 not counted | ||||||
MIO-M1 retinal Muller glia aminooxy-biotin surfaceome Study list, tab “lorenz-muller-2021”raw data not deposited | 2021 | Intact-cell labeling | Glycoprotein capture | Muller glia cell line Neural cells | 423 | 66%66% of this dataset's proteins are Canonical or Likely in our Surfaceome; datasets without published amounts need at least 20% of their proteins (the tick), or are Provisional within 2 points below it. | HeldHeld: the published table can't yet tell us which proteins were detected, for example conditions are pooled with no separable baseline. Listed, not counted. not counted conditions are pooled in one list, with no separable baseline | |
MCF7 galactose-oxidase/hydrazide surface glycoprotein capture with in situ crosslinking Study list, tab “sun-mcf7-xlink-gao-2021”raw data not deposited | 2021 | Intact-cell labeling | Glycoprotein capture | Breast cancer cell line Solid tumors | 3,223 | 23%23% of this dataset's proteins are Canonical or Likely in our Surfaceome; datasets without published amounts need at least 20% of their proteins (the tick), or are Provisional within 2 points below it. | HeldHeld: the published table can't yet tell us which proteins were detected, for example conditions are pooled with no separable baseline. Listed, not counted. not counted the sample-to-condition map is unpublished | |
Blood outgrowth endothelial cell sulfo-NHS-LC-biotin site footprint under shear | 2020 | Intact-cell labeling | Amine biotinylation | Primary endothelial cells Other normal cells | 286 | 52%52% of this dataset's proteins are Canonical or Likely in our Surfaceome; datasets without published amounts need at least 20% of their proteins (the tick), or are Provisional within 2 points below it. | HeldHeld: the published table can't yet tell us which proteins were detected, for example conditions are pooled with no separable baseline. Listed, not counted. not counted the sample-to-condition map is unpublished | |
Brain microvascular and umbilical vein endothelial sulfo-NHS surfaceome Study list, tab “ito-bbb-2020”raw data not deposited | 2020 | Intact-cell labeling | Amine biotinylation | Endothelial cell line and primary endothelial cells Other normal cells | 439 | 59%59% of this dataset's proteins are Canonical or Likely in our Surfaceome; datasets without published amounts need at least 20% of their proteins (the tick), or are Provisional within 2 points below it. | HeldHeld: the published table can't yet tell us which proteins were detected, for example conditions are pooled with no separable baseline. Listed, not counted. not counted only proteins above an enrichment cutoff are reported | |
Oncogene surfaceome Study list, tab “leung-2020”PRIDE PXD017039: raw files | 2020 | Intact-cell labeling | Glycopeptide capture | MCF10A breast epithelial isogenic oncogene panel; condition mixture unresolved Other normal cells | 648 | 67%67% of this dataset's proteins are Canonical or Likely in our Surfaceome; datasets without published amounts need at least 20% of their proteins (the tick), or are Provisional within 2 points below it. | HeldHeld: the published table can't yet tell us which proteins were detected, for example conditions are pooled with no separable baseline. Listed, not counted. not counted only biological comparisons are published, not a baseline list | |
Pharmacological induction of selective endoplasmic reticulum retention as a strategy for cancer therapy | 2020 | 2 datasets: 0 counted, 2 not counted | ||||||
Blood outgrowth endothelial cell sulfo-NHS-LC-biotin site footprint, mock/TNF/IL-1 SILAC | 2019 | Intact-cell labeling | Amine biotinylation | Primary endothelial cells Other normal cells | 485 | 38%38% of this dataset's proteins are Canonical or Likely in our Surfaceome; datasets without published amounts need at least 20% of their proteins (the tick), or are Provisional within 2 points below it. | HeldHeld: the published table can't yet tell us which proteins were detected, for example conditions are pooled with no separable baseline. Listed, not counted. not counted the sample-to-condition map is unpublished | |
Erythrocyte plasma membrane profiling, Lan-null and control donors pooled | 2018 | Intact-cell labeling | Glycoprotein capture | Primary blood cells (erythrocytes) Other normal cells | 684 | 45%45% of this dataset's proteins are Canonical or Likely in our Surfaceome; datasets without published amounts need at least 20% of their proteins (the tick), or are Provisional within 2 points below it. | HeldHeld: the published table can't yet tell us which proteins were detected, for example conditions are pooled with no separable baseline. Listed, not counted. not counted the sample-to-condition map is unpublished | |
Improved surfaceome coverage with a label-free nonaffinity-purified workflow | 2017 | 2 datasets: 0 counted, 2 not counted | ||||||
Identification of senescent cell surface targetable protein DPP4 | 2017 | 4 datasets: 0 counted, 4 not counted | ||||||
Dental pulp MSC sulfo-NHS-SS-biotin surfaceome Study list, tab “niehage-dpsc-2016”raw data not deposited | 2016 | Intact-cell labeling | Amine biotinylation | Primary mesenchymal stromal cells Stem & stromal | 3,326 | 17%17% of this dataset's proteins are Canonical or Likely in our Surfaceome; datasets without published amounts need at least 20% of their proteins (the tick), or are Provisional within 2 points below it. | HeldHeld: the published table can't yet tell us which proteins were detected, for example conditions are pooled with no separable baseline. Listed, not counted. not counted the pull-downs are barely enriched over total lysate | |
AML patient leukemia cell surface sulfo-NHS-SS-biotin capture, absolute quantification Study list, tab “wang-aml-surface-2015”raw data not deposited | 2015 | Intact-cell labeling | Amine biotinylation | Primary AML patient cells Blood cancers | 4,176 | 9%9% of this dataset's proteins are Canonical or Likely in our Surfaceome; datasets without published amounts need at least 20% of their proteins (the tick), or are Provisional within 2 points below it. | HeldHeld: the published table can't yet tell us which proteins were detected, for example conditions are pooled with no separable baseline. Listed, not counted. not counted the total-lysate table needed to remove contaminants isn't public | |
HNSCC tumor spheres and adherent cells, pooled four lines, sulfo-NHS surfaceome Study list, tab “yan-hnscc-spheres-2013”raw data not deposited | 2013 | Intact-cell labeling | Amine biotinylation | Cancer cell lines (head and neck squamous cell carcinoma) Solid tumors | 372 | 17%17% of this dataset's proteins are Canonical or Likely in our Surfaceome; datasets without published amounts need at least 20% of their proteins (the tick), or are Provisional within 2 points below it. | HeldHeld: the published table can't yet tell us which proteins were detected, for example conditions are pooled with no separable baseline. Listed, not counted. not counted each sample mixes several cell lines, so membership can't be stated per line | |
Endometrial cancer and normal endometrial lines, cell-surface biotinylation iTRAQ Study list, tab “yokoyama-endometrial-2013”raw data not deposited | 2013 | Intact-cell labeling | Amine biotinylation | Cancer and normal endometrial cell lines Solid tumors | 249 | 53%53% of this dataset's proteins are Canonical or Likely in our Surfaceome; datasets without published amounts need at least 20% of their proteins (the tick), or are Provisional within 2 points below it. | HeldHeld: the published table can't yet tell us which proteins were detected, for example conditions are pooled with no separable baseline. Listed, not counted. not counted conditions are pooled in one list, with no separable baseline | |
Hepatocellular carcinoma cell surface N-glycopeptide capture, modified CSC Study list, tab “mi-hcc-csc-2012”raw data not deposited | 2012 | Intact-cell labeling | Glycopeptide capture | Hepatocellular carcinoma cell line Solid tumors | 78 | 63%63% of this dataset's proteins are Canonical or Likely in our Surfaceome; datasets without published amounts need at least 20% of their proteins (the tick), or are Provisional within 2 points below it. | HeldHeld: the published table can't yet tell us which proteins were detected, for example conditions are pooled with no separable baseline. Listed, not counted. not counted the cell line, and whether runs were pooled, aren't stated | |
The microcephaly-associated protein YIPF5 differentially regulates ER export | 2026 | 4 datasets: 0 counted, 4 not counted | ||||||
Patient-derived glioblastoma stem-like cultures, sulfo-NHS surfaceome | 2026 | Intact-cell labeling | Amine biotinylation | Patient-derived GBM stem-like cultures Solid tumors | 4,708 | 23%amount23% of this dataset's length-corrected protein amount is Canonical or Likely in our Surfaceome (15% of its proteins). Datasets whose table reports amounts need at least 25% of their amount (the tick). | High backgroundHigh background: intact-cell labeling, but under the surface screen (25% of its length-corrected amount, or 20% of its list when no amounts are published, are Canonical or Likely Surfaceome proteins), so it is mostly intracellular contamination. Listed, not counted. not counted 22.8% of its length-corrected amount in Canonical or Likely proteins, under 25% | |
Brain endothelial and HUVEC sulfo-NHS surfaceomes with no-biotin controls | 2025 | Intact-cell labeling | Amine biotinylation | Brain microvascular endothelial cells (stem-cell derived and line) and umbilical vein endothelial cells Other normal cells | 4,250 | 11%amount11% of this dataset's length-corrected protein amount is Canonical or Likely in our Surfaceome (10% of its proteins). Datasets whose table reports amounts need at least 25% of their amount (the tick). | High backgroundHigh background: intact-cell labeling, but under the surface screen (25% of its length-corrected amount, or 20% of its list when no amounts are published, are Canonical or Likely Surfaceome proteins), so it is mostly intracellular contamination. Listed, not counted. not counted 10.9% of its length-corrected amount in Canonical or Likely proteins, under 25% | |
Microglia WGA-HRP Study list, tab “holmes-2025”PRIDE PXD060977: raw files | 2025 | Intact-cell labeling | Proximity labelingPeroxidase or laccase proximity labeling | iPSC-derived induced-transcription-factor microglia (WTC11 background) Neural cells | 1,096 | 35%35% of this dataset's proteins are Canonical or Likely in our Surfaceome; datasets without published amounts need at least 20% of their proteins (the tick), or are Provisional within 2 points below it. | High backgroundHigh background: intact-cell labeling, but under the surface screen (25% of its length-corrected amount, or 20% of its list when no amounts are published, are Canonical or Likely Surfaceome proteins), so it is mostly intracellular contamination. Listed, not counted. not counted pre-filtered list below its raised bar (35% vs 57%) | |
AMO-1 and MM.1S myeloma periodate/biocytin-hydrazide surfaceome Study list, tab “kasap-myeloma-csc-2025”PRIDE PXD048492: processed files only, no raw files | 2025 | Intact-cell labeling | Glycoprotein capture | Multiple myeloma cell lines Blood cancers | 4,886 | 19%amount19% of this dataset's length-corrected protein amount is Canonical or Likely in our Surfaceome (11% of its proteins). Datasets whose table reports amounts need at least 25% of their amount (the tick). | High backgroundHigh background: intact-cell labeling, but under the surface screen (25% of its length-corrected amount, or 20% of its list when no amounts are published, are Canonical or Likely Surfaceome proteins), so it is mostly intracellular contamination. Listed, not counted. not counted 19.2% of its length-corrected amount in Canonical or Likely proteins, under 25% | |
KMT2A-rearranged B-ALL PDX cells, sulfo-NHS-LC-biotin surfaceome with no-biotin controls | 2025 | Intact-cell labeling | Amine biotinylation | Primary leukemia (patient-derived xenograft) Blood cancers | 4,653 | 15%amount15% of this dataset's length-corrected protein amount is Canonical or Likely in our Surfaceome (10% of its proteins). Datasets whose table reports amounts need at least 25% of their amount (the tick). | High backgroundHigh background: intact-cell labeling, but under the surface screen (25% of its length-corrected amount, or 20% of its list when no amounts are published, are Canonical or Likely Surfaceome proteins), so it is mostly intracellular contamination. Listed, not counted. not counted 15.2% of its length-corrected amount in Canonical or Likely proteins, under 25% | |
JMML and healthy-donor CD34+ cells, WGA-HRP surface biotinylation Study list, tab “werner-jmml-cd34-2025”PRIDE PXD052910: processed files only, no raw files | 2025 | Intact-cell labeling | Proximity labelingPeroxidase or laccase proximity labeling | Primary leukemia and healthy-donor hematopoietic progenitors Blood cancers | 4,163 | 12%amount12% of this dataset's length-corrected protein amount is Canonical or Likely in our Surfaceome (8% of its proteins). Datasets whose table reports amounts need at least 25% of their amount (the tick). | High backgroundHigh background: intact-cell labeling, but under the surface screen (25% of its length-corrected amount, or 20% of its list when no amounts are published, are Canonical or Likely Surfaceome proteins), so it is mostly intracellular contamination. Listed, not counted. not counted 11.8% of its length-corrected amount in Canonical or Likely proteins, under 25% | |
Hypoxic GBM TS-MAP | 2024 | Intact-cell labeling | Amine biotinylation | Glioblastoma cultures U3034, U3017, U3047 and AB1; exact AB1 line identity unresolved Solid tumors | 4,424 | 15%15% of this dataset's proteins are Canonical or Likely in our Surfaceome; datasets without published amounts need at least 20% of their proteins (the tick), or are Provisional within 2 points below it. | High backgroundHigh background: intact-cell labeling, but under the surface screen (25% of its length-corrected amount, or 20% of its list when no amounts are published, are Canonical or Likely Surfaceome proteins), so it is mostly intracellular contamination. Listed, not counted. not counted 15% Canonical or Likely proteins, under 20% | |
Human primary dendritic cells Study list, tab “udeshi-2024”raw data not deposited | 2024 | Intact-cell labeling | Amine biotinylation | Primary unstimulated dendritic cells; pooled-donor TMT experiments Immune cells | 2,583 | 12%12% of this dataset's proteins are Canonical or Likely in our Surfaceome; datasets without published amounts need at least 20% of their proteins (the tick), or are Provisional within 2 points below it. | High backgroundHigh background: intact-cell labeling, but under the surface screen (25% of its length-corrected amount, or 20% of its list when no amounts are published, are Canonical or Likely Surfaceome proteins), so it is mostly intracellular contamination. Listed, not counted. not counted 12% Canonical or Likely proteins, under 20% | |
Retinoblastoma Y79 and RB383 sulfo-NHS-SS-biotin surfaceomes | 2023 | Intact-cell labeling | Amine biotinylation | Retinoblastoma cell lines (one patient-derived) Solid tumors | 2,894 | 8%8% of this dataset's proteins are Canonical or Likely in our Surfaceome; datasets without published amounts need at least 20% of their proteins (the tick), or are Provisional within 2 points below it. | High backgroundHigh background: intact-cell labeling, but under the surface screen (25% of its length-corrected amount, or 20% of its list when no amounts are published, are Canonical or Likely Surfaceome proteins), so it is mostly intracellular contamination. Listed, not counted. not counted 8% Canonical or Likely proteins, under 20% | |
Temporal Tracking of Insulin Action on the Cell Surface of Proteins at a Resolution of Ten Seconds | 2023 | 9 datasets: 0 counted, 9 not counted | ||||||
Nomo-1 AML periodate/biocytin-hydrazide surfaceome | 2023 | Intact-cell labeling | Glycoprotein capture | Leukemia cell line Blood cancers | 5,413 | 13%13% of this dataset's proteins are Canonical or Likely in our Surfaceome; datasets without published amounts need at least 20% of their proteins (the tick), or are Provisional within 2 points below it. | High backgroundHigh background: intact-cell labeling, but under the surface screen (25% of its length-corrected amount, or 20% of its list when no amounts are published, are Canonical or Likely Surfaceome proteins), so it is mostly intracellular contamination. Listed, not counted. not counted 13% Canonical or Likely proteins, under 20% | |
Defining the proteomic landscape of cultured macrophages and their polarization continuum | 2023 | 7 datasets: 0 counted, 7 not counted | ||||||
Nasopharyngeal carcinoma 6-10B / 5-8F surface biotinylation + SILAC Study list, tab “li-npc-2021”raw data not deposited | 2021 | Intact-cell labeling | Amine biotinylation | NPC cell lines Solid tumors | 2,473 | 11%11% of this dataset's proteins are Canonical or Likely in our Surfaceome; datasets without published amounts need at least 20% of their proteins (the tick), or are Provisional within 2 points below it. | High backgroundHigh background: intact-cell labeling, but under the surface screen (25% of its length-corrected amount, or 20% of its list when no amounts are published, are Canonical or Likely Surfaceome proteins), so it is mostly intracellular contamination. Listed, not counted. not counted 11% Canonical or Likely proteins, under 20% | |
HCT116 colorectal cancer sulfo-NHS surface biotinylation with Dounce lysis Study list, tab “barua-hct116-2020”raw data not deposited | 2020 | Intact-cell labeling | Amine biotinylation | Cancer cell line Solid tumors | 299 | 13%13% of this dataset's proteins are Canonical or Likely in our Surfaceome; datasets without published amounts need at least 20% of their proteins (the tick), or are Provisional within 2 points below it. | High backgroundHigh background: intact-cell labeling, but under the surface screen (25% of its length-corrected amount, or 20% of its list when no amounts are published, are Canonical or Likely Surfaceome proteins), so it is mostly intracellular contamination. Listed, not counted. not counted 13% Canonical or Likely proteins, under 20% | |
Lung cancer 95C / 95D Pierce surface-kit proteome | 2020 | Intact-cell labeling | Amine biotinylation | NSCLC cell lines Solid tumors | 2,786 | 15%amount15% of this dataset's length-corrected protein amount is Canonical or Likely in our Surfaceome (8% of its proteins). Datasets whose table reports amounts need at least 25% of their amount (the tick). | High backgroundHigh background: intact-cell labeling, but under the surface screen (25% of its length-corrected amount, or 20% of its list when no amounts are published, are Canonical or Likely Surfaceome proteins), so it is mostly intracellular contamination. Listed, not counted. not counted 14.5% of its length-corrected amount in Canonical or Likely proteins, under 25% | |
HeLa optimized sulfo-NHS-SS-biotin surfaceome, new protocol | 2019 | Intact-cell labeling | Amine biotinylation | Cancer cell line Solid tumors | 2,919 | 15%15% of this dataset's proteins are Canonical or Likely in our Surfaceome; datasets without published amounts need at least 20% of their proteins (the tick), or are Provisional within 2 points below it. | High backgroundHigh background: intact-cell labeling, but under the surface screen (25% of its length-corrected amount, or 20% of its list when no amounts are published, are Canonical or Likely Surfaceome proteins), so it is mostly intracellular contamination. Listed, not counted. not counted 15% Canonical or Likely proteins, under 20% | |
Glioblastoma lines, GBM stem cells and neural stem cells sulfo-NHS surfaceome Study list, tab “ghosh-gbm-2017”raw data not deposited | 2017 | Intact-cell labeling | Amine biotinylation | Glioblastoma cell lines, cancer stem cells and neural stem cells Solid tumors | 1,178 | 16%16% of this dataset's proteins are Canonical or Likely in our Surfaceome; datasets without published amounts need at least 20% of their proteins (the tick), or are Provisional within 2 points below it. | High backgroundHigh background: intact-cell labeling, but under the surface screen (25% of its length-corrected amount, or 20% of its list when no amounts are published, are Canonical or Likely Surfaceome proteins), so it is mostly intracellular contamination. Listed, not counted. not counted 16% Canonical or Likely proteins, under 20% | |
AML CAR-target Study list, tab “perna-2017”PRIDE PXD007552: raw files | 2017 | Intact-cell labeling | Amine biotinylation | AML lines THP-1, Mono-Mac, Kasumi-1, MOLM-13, OCI-AML3 and TF-1 Blood cancers | 3,308 | 8%8% of this dataset's proteins are Canonical or Likely in our Surfaceome; datasets without published amounts need at least 20% of their proteins (the tick), or are Provisional within 2 points below it. | High backgroundHigh background: intact-cell labeling, but under the surface screen (25% of its length-corrected amount, or 20% of its list when no amounts are published, are Canonical or Likely Surfaceome proteins), so it is mostly intracellular contamination. Listed, not counted. not counted 8% Canonical or Likely proteins, under 20% | |
AMP-Activated Protein Kinase Regulates the Cell Surface Proteome and Integrin Membrane Traffic | 2015 | 2 datasets: 0 counted, 2 not counted | ||||||
MDA-MB-453 parental and CSC-like in-situ cell-surface biotinylation Study list, tab “kang-mda453-csc-2013”raw data not deposited | 2013 | Intact-cell labeling | Amine biotinylation | Breast cancer cell line Solid tumors | 2,698 | 12%12% of this dataset's proteins are Canonical or Likely in our Surfaceome; datasets without published amounts need at least 20% of their proteins (the tick), or are Provisional within 2 points below it. | High backgroundHigh background: intact-cell labeling, but under the surface screen (25% of its length-corrected amount, or 20% of its list when no amounts are published, are Canonical or Likely Surfaceome proteins), so it is mostly intracellular contamination. Listed, not counted. not counted 12% Canonical or Likely proteins, under 20% | |
A431 epidermoid carcinoma cell-surface biotin capture, SILAC untreated vs gefitinib Study list, tab “kani-a431-gefitinib-2012”raw data not deposited | 2012 | Intact-cell labeling | Amine biotinylation | Epidermoid carcinoma cell line Solid tumors | 693 | 16%16% of this dataset's proteins are Canonical or Likely in our Surfaceome; datasets without published amounts need at least 20% of their proteins (the tick), or are Provisional within 2 points below it. | High backgroundHigh background: intact-cell labeling, but under the surface screen (25% of its length-corrected amount, or 20% of its list when no amounts are published, are Canonical or Likely Surfaceome proteins), so it is mostly intracellular contamination. Listed, not counted. not counted 16% Canonical or Likely proteins, under 20% | |
PC3-derived N2 and ML2 prostate cancer lines, metabolic-azide surface sialoglycoproteome Study list, tab “yang-pc3-sialo-2011”raw data not deposited | 2011 | Intact-cell labeling | Glycoprotein capture | Prostate cancer cell lines Solid tumors | 511 | 10%10% of this dataset's proteins are Canonical or Likely in our Surfaceome; datasets without published amounts need at least 20% of their proteins (the tick), or are Provisional within 2 points below it. | High backgroundHigh background: intact-cell labeling, but under the surface screen (25% of its length-corrected amount, or 20% of its list when no amounts are published, are Canonical or Likely Surfaceome proteins), so it is mostly intracellular contamination. Listed, not counted. not counted 10% Canonical or Likely proteins, under 20% | |
SH-SY5Y neuroblastoma sulfo-NHS biotin surface proteome, avidin column Study list, tab “garcia-shsy5y-2009”raw data not deposited | 2009 | Intact-cell labeling | Amine biotinylation | Neuroblastoma cell line Solid tumors | 2,316 | 15%amount15% of this dataset's length-corrected protein amount is Canonical or Likely in our Surfaceome (10% of its proteins). Datasets whose table reports amounts need at least 25% of their amount (the tick). | High backgroundHigh background: intact-cell labeling, but under the surface screen (25% of its length-corrected amount, or 20% of its list when no amounts are published, are Canonical or Likely Surfaceome proteins), so it is mostly intracellular contamination. Listed, not counted. not counted 14.8% of its length-corrected amount in Canonical or Likely proteins, under 25% | |
Ovarian cancer lines and ascites tumor cells sulfo-NHS-SS-biotin surfaceome Study list, tab “faca-ovarian-2008”raw data not deposited | 2008 | Intact-cell labeling | Amine biotinylation | Ovarian cancer cell lines and primary ascites tumor cells Solid tumors | 3,009 | 19%amount19% of this dataset's length-corrected protein amount is Canonical or Likely in our Surfaceome (16% of its proteins). Datasets whose table reports amounts need at least 25% of their amount (the tick). | High backgroundHigh background: intact-cell labeling, but under the surface screen (25% of its length-corrected amount, or 20% of its list when no amounts are published, are Canonical or Likely Surfaceome proteins), so it is mostly intracellular contamination. Listed, not counted. not counted 19.3% of its length-corrected amount in Canonical or Likely proteins, under 25% | |
Human cell line affinity-purified plasma membrane, surface biotinylation Study list, tab “zhao-pm-affinity-2003”raw data not deposited | 2003 | Intact-cell labeling | Amine biotinylation | Cell line (unnamed) Other normal cells | 662 | 13%13% of this dataset's proteins are Canonical or Likely in our Surfaceome; datasets without published amounts need at least 20% of their proteins (the tick), or are Provisional within 2 points below it. | High backgroundHigh background: intact-cell labeling, but under the surface screen (25% of its length-corrected amount, or 20% of its list when no amounts are published, are Canonical or Likely Surfaceome proteins), so it is mostly intracellular contamination. Listed, not counted. not counted 13% Canonical or Likely proteins, under 20% | |
Malignant rhabdoid tumor and matched normal kidney organoid surface proteome, membrane-annotated list | 2026 | Intact-cell labeling | Other chemistryOther chemoproteomic labeling | Pediatric tumor and normal kidney organoids Solid tumors | 348 | 68%68% of this dataset's proteins are Canonical or Likely in our Surfaceome; datasets without published amounts need at least 20% of their proteins (the tick), or are Provisional within 2 points below it. | Pre-filteredPre-filtered by surface annotation (shown, not counted): the published table was already restricted to proteins annotated or predicted as surface or membrane proteins. Such a table cannot add a candidate or reveal a miss, and it would inflate the share of known surface proteins that the quality screen measures, so it is shown, cited only as support for proteins already in the reference, and never counted. not counted author pre-filtered to annotated surface proteins | |
Culture-Associated Changes in the Human Cardiac Fibroblast Surfaceome: A Proteomic Resource for Cell Surface Marker and Target Discovery | 2026 | 5 datasets: 0 counted, 5 not counted | ||||||
Microscaled Cell Surface Proteomics for Cryo-Preserved Cells and Tissue Samples | 2025 | 2 datasets: 0 counted, 2 not counted | ||||||
Senescence surfaceome | 2024 | Intact-cell labeling | Amine biotinylation | Normal human lung fibroblasts (NHLF) and umbilical-vein endothelial cells (HUVEC) Other normal cells | 966 | 23%23% of this dataset's proteins are Canonical or Likely in our Surfaceome; datasets without published amounts need at least 20% of their proteins (the tick), or are Provisional within 2 points below it. | Pre-filteredPre-filtered by surface annotation (shown, not counted): the published table was already restricted to proteins annotated or predicted as surface or membrane proteins. Such a table cannot add a candidate or reveal a miss, and it would inflate the share of known surface proteins that the quality screen measures, so it is shown, cited only as support for proteins already in the reference, and never counted. not counted author pre-filtered to membrane- or surface-annotated proteins | |
CellSurfer cardiac | 2023 | Intact-cell labeling | Glycopeptide capture | Adult donor-heart cardiomyocytes, fibroblasts, microvascular endothelial and coronary smooth-muscle cells Other normal cells | 1,140 | 60%60% of this dataset's proteins are Canonical or Likely in our Surfaceome; datasets without published amounts need at least 20% of their proteins (the tick), or are Provisional within 2 points below it. | Pre-filteredPre-filtered by surface annotation (shown, not counted): the published table was already restricted to proteins annotated or predicted as surface or membrane proteins. Such a table cannot add a candidate or reveal a miss, and it would inflate the share of known surface proteins that the quality screen measures, so it is shown, cited only as support for proteins already in the reference, and never counted. not counted author pre-filtered to transmembrane or signal-peptide proteins | |
Cell Surface Engineering Enables Surfaceome Profiling | 2023 | 2 datasets: 0 counted, 2 not counted | ||||||
Optimized CSC AML Study list, tab “optimized-csc-aml-2022”raw data not deposited | 2022 | Intact-cell labeling | Glycopeptide capture | Primary AML specimens, patient-derived xenografts and AML cell lines Blood cancers | 568 | 64%64% of this dataset's proteins are Canonical or Likely in our Surfaceome; datasets without published amounts need at least 20% of their proteins (the tick), or are Provisional within 2 points below it. | Pre-filteredPre-filtered by surface annotation (shown, not counted): the published table was already restricted to proteins annotated or predicted as surface or membrane proteins. Such a table cannot add a candidate or reveal a miss, and it would inflate the share of known surface proteins that the quality screen measures, so it is shown, cited only as support for proteins already in the reference, and never counted. not counted author pre-filtered to transmembrane or signal-peptide proteins | |
Monocyte subsets PMP | 2020 | Intact-cell labeling | Glycoprotein capture | Primary classical monocytes Immune cells | 511 | 66%66% of this dataset's proteins are Canonical or Likely in our Surfaceome; datasets without published amounts need at least 20% of their proteins (the tick), or are Provisional within 2 points below it. | Pre-filteredPre-filtered by surface annotation (shown, not counted): the published table was already restricted to proteins annotated or predicted as surface or membrane proteins. Such a table cannot add a candidate or reveal a miss, and it would inflate the share of known surface proteins that the quality screen measures, so it is shown, cited only as support for proteins already in the reference, and never counted. not counted author pre-filtered to membrane- or surface-annotated proteins | |
Leung 2019 (Veneer reanalysis) Study list, tab “leung-2019”raw data not deposited | 2019 | Intact-cell labeling | Glycopeptide capture | AML lines KG1a, HL60, HNT34 and AML193; vehicle/azacitidine conditions pooled in reanalysis Blood cancers | 862 | 65%65% of this dataset's proteins are Canonical or Likely in our Surfaceome; datasets without published amounts need at least 20% of their proteins (the tick), or are Provisional within 2 points below it. | Pre-filteredPre-filtered by surface annotation (shown, not counted): the published table was already restricted to proteins annotated or predicted as surface or membrane proteins. Such a table cannot add a candidate or reveal a miss, and it would inflate the share of known surface proteins that the quality screen measures, so it is shown, cited only as support for proteins already in the reference, and never counted. not counted author pre-filtered to annotated surface proteins | |
Chondroprogenitor/MSC PMP Study list, tab “matta-2019”raw data not deposited | 2019 | Intact-cell labeling | Glycoprotein capture | Osteoarthritic-cartilage chondroprogenitors and bone-marrow mesenchymal stromal cells Stem & stromal | 780 | 51%51% of this dataset's proteins are Canonical or Likely in our Surfaceome; datasets without published amounts need at least 20% of their proteins (the tick), or are Provisional within 2 points below it. | Pre-filteredPre-filtered by surface annotation (shown, not counted): the published table was already restricted to proteins annotated or predicted as surface or membrane proteins. Such a table cannot add a candidate or reveal a miss, and it would inflate the share of known surface proteins that the quality screen measures, so it is shown, cited only as support for proteins already in the reference, and never counted. not counted author pre-filtered to transmembrane or signal-peptide proteins | |
Kalxdorf 2017 (Veneer reanalysis) | 2017 | Intact-cell labeling | Glycoprotein capture | Monocyte/macrophage differentiation and primary hematopoietic-cell comparisons; pooled reanalysis conditions Immune cells | 1,388 | 72%72% of this dataset's proteins are Canonical or Likely in our Surfaceome; datasets without published amounts need at least 20% of their proteins (the tick), or are Provisional within 2 points below it. | Pre-filteredPre-filtered by surface annotation (shown, not counted): the published table was already restricted to proteins annotated or predicted as surface or membrane proteins. Such a table cannot add a candidate or reveal a miss, and it would inflate the share of known surface proteins that the quality screen measures, so it is shown, cited only as support for proteins already in the reference, and never counted. not counted author pre-filtered to annotated surface proteins | |
MCF-7 metabolic-labeling surface glycoproteins, Veneer reanalysis Study list, tab “xiao-mcf7-2017”raw data not deposited | 2017 | Intact-cell labeling | Glycoprotein capture | Breast cancer line Solid tumors | 265 | 86%86% of this dataset's proteins are Canonical or Likely in our Surfaceome; datasets without published amounts need at least 20% of their proteins (the tick), or are Provisional within 2 points below it. | Pre-filteredPre-filtered by surface annotation (shown, not counted): the published table was already restricted to proteins annotated or predicted as surface or membrane proteins. Such a table cannot add a candidate or reveal a miss, and it would inflate the share of known surface proteins that the quality screen measures, so it is shown, cited only as support for proteins already in the reference, and never counted. not counted author pre-filtered to annotated surface proteins | |
Neural precursor and hNT neuron CSC surfaceome, Veneer reanalysis Study list, tab “tyleckova-npc-2016”raw data not deposited | 2016 | Intact-cell labeling | Glycopeptide capture | Neural precursors and neurons Neural cells | 521 | 58%58% of this dataset's proteins are Canonical or Likely in our Surfaceome; datasets without published amounts need at least 20% of their proteins (the tick), or are Provisional within 2 points below it. | Pre-filteredPre-filtered by surface annotation (shown, not counted): the published table was already restricted to proteins annotated or predicted as surface or membrane proteins. Such a table cannot add a candidate or reveal a miss, and it would inflate the share of known surface proteins that the quality screen measures, so it is shown, cited only as support for proteins already in the reference, and never counted. not counted author pre-filtered to annotated surface proteins | |
MSC surfaceome Study list, tab “msc-hoflack-2011”raw data not deposited | 2011 | Intact-cell labeling | Amine biotinylation | Healthy-donor bone-marrow mesenchymal stromal cells Stem & stromal | 175 | 60%60% of this dataset's proteins are Canonical or Likely in our Surfaceome; datasets without published amounts need at least 20% of their proteins (the tick), or are Provisional within 2 points below it. | Pre-filteredPre-filtered by surface annotation (shown, not counted): the published table was already restricted to proteins annotated or predicted as surface or membrane proteins. Such a table cannot add a candidate or reveal a miss, and it would inflate the share of known surface proteins that the quality screen measures, so it is shown, cited only as support for proteins already in the reference, and never counted. not counted author pre-filtered to transmembrane or signal-peptide proteins | |
MSI colorectal cancer organoid Mem-PER Plus membranes | 2026 | Membrane fractionation | Membrane fractionation | Colorectal cancer organoids Solid tumors | 8,287 | 8%8% of this dataset's proteins are Canonical or Likely in our Surfaceome. | Membrane fractionMembrane fraction: cells broken open and membranes purified, so it shows a protein is on a membrane (internal membranes included), not that it faces outward. Listed for comparison, not counted. One dataset here is instead an intact-cell label that reaches the inner side of the membrane, marked Inner-side labeling. not counted cells broken open and membranes purified, so it can't show a protein faces outward | |
PC3 prostate cancer Mem-PER Plus membranes, TMT | 2026 | Membrane fractionation | Membrane fractionation | Prostate cancer line Solid tumors | 5,712 | 9%9% of this dataset's proteins are Canonical or Likely in our Surfaceome. | Membrane fractionMembrane fraction: cells broken open and membranes purified, so it shows a protein is on a membrane (internal membranes included), not that it faces outward. Listed for comparison, not counted. One dataset here is instead an intact-cell label that reaches the inner side of the membrane, marked Inner-side labeling. not counted cells broken open and membranes purified, so it can't show a protein faces outward | |
Secretome translation shaped by lysosomes and lunapark-marked ER junctions | 2026 | 2 datasets: 0 counted, 2 not counted | ||||||
Triple-negative breast cancer lines and MCF-12F mixed membrane fractions, label-free HDMSE | 2026 | Membrane fractionation | Membrane fractionation | Cell lines (non-tumorigenic breast epithelial and TNBC) Solid tumors | 4,858 | 11%11% of this dataset's proteins are Canonical or Likely in our Surfaceome. | Membrane fractionMembrane fraction: cells broken open and membranes purified, so it shows a protein is on a membrane (internal membranes included), not that it faces outward. Listed for comparison, not counted. One dataset here is instead an intact-cell label that reaches the inner side of the membrane, marked Inner-side labeling. not counted cells broken open and membranes purified, so it can't show a protein faces outward | |
Endothelial, pericyte and astrocyte Qproteome membrane fractions Study list, tab “dusailly-ec-2026”raw data not deposited | 2026 | Membrane fractionation | Membrane fractionation | Endothelial cells, pericytes, astrocytes Other normal cells | 3,020 | 11%11% of this dataset's proteins are Canonical or Likely in our Surfaceome. | Membrane fractionMembrane fraction: cells broken open and membranes purified, so it shows a protein is on a membrane (internal membranes included), not that it faces outward. Listed for comparison, not counted. One dataset here is instead an intact-cell label that reaches the inner side of the membrane, marked Inner-side labeling. not counted cells broken open and membranes purified, so it can't show a protein faces outward | |
Osteosarcoma PDX surface-enriched proteome | 2026 | Membrane fractionation | Membrane fractionation | Osteosarcoma PDX Solid tumors | 2,159 | 21%21% of this dataset's proteins are Canonical or Likely in our Surfaceome. | Membrane fractionMembrane fraction: cells broken open and membranes purified, so it shows a protein is on a membrane (internal membranes included), not that it faces outward. Listed for comparison, not counted. One dataset here is instead an intact-cell label that reaches the inner side of the membrane, marked Inner-side labeling. not counted cells broken open and membranes purified, so it can't show a protein faces outward | |
Glioblastoma invasive-margin kit membrane fraction | 2026 | Membrane fractionation | Membrane fractionation | Patient-derived GBM lines and astrocytes Solid tumors | 4,665 | 11%11% of this dataset's proteins are Canonical or Likely in our Surfaceome. | Membrane fractionMembrane fraction: cells broken open and membranes purified, so it shows a protein is on a membrane (internal membranes included), not that it faces outward. Listed for comparison, not counted. One dataset here is instead an intact-cell label that reaches the inner side of the membrane, marked Inner-side labeling. not counted cells broken open and membranes purified, so it can't show a protein faces outward | |
HUVEC crude membrane pellet under static and flow conditions | 2026 | Membrane fractionation | Membrane fractionation | Primary endothelial cells (HUVEC) Other normal cells | 2,915 | 11%11% of this dataset's proteins are Canonical or Likely in our Surfaceome. | Membrane fractionMembrane fraction: cells broken open and membranes purified, so it shows a protein is on a membrane (internal membranes included), not that it faces outward. Listed for comparison, not counted. One dataset here is instead an intact-cell label that reaches the inner side of the membrane, marked Inner-side labeling. not counted cells broken open and membranes purified, so it can't show a protein faces outward | |
Differential unfolded protein response regulation in KRAS silencing sensitive and innately resistant colorectal cancer cells | 2025 | 5 datasets: 0 counted, 5 not counted | ||||||
Membrane proteomics in P493-6 cells treated with NMTi (PRIDE PXD054019; publication pending) | 2025 | 2 datasets: 0 counted, 2 not counted | ||||||
Membrane proteomics in SHEP21N cells treated with NMTi (PRIDE PXD054008; publication pending) | 2025 | 2 datasets: 0 counted, 2 not counted | ||||||
Targeted and Untargeted Proteomics-based Comparison of Adenoviral Infected hCMEC/D3 and hBMEC as a Human Brain Endothelial Cells to Study the OATP2B1 Transporter | 2025 | 3 datasets: 0 counted, 3 not counted | ||||||
Pancreatic cancer xenograft plasma-membrane fraction, AP2S1 knockout series | 2025 | Membrane fractionation | Membrane fractionation | Cancer cell-line xenografts Solid tumors | 6,540 | 14%14% of this dataset's proteins are Canonical or Likely in our Surfaceome. | Membrane fractionMembrane fraction: cells broken open and membranes purified, so it shows a protein is on a membrane (internal membranes included), not that it faces outward. Listed for comparison, not counted. One dataset here is instead an intact-cell label that reaches the inner side of the membrane, marked Inner-side labeling. not counted cells broken open and membranes purified, so it can't show a protein faces outward | |
Neuroblastoma cell-line plasma-membrane proteome | 2024 | Membrane fractionation | Membrane fractionation | Neuroblastoma cell lines Solid tumors | 6,904 | 14%14% of this dataset's proteins are Canonical or Likely in our Surfaceome. | Membrane fractionMembrane fraction: cells broken open and membranes purified, so it shows a protein is on a membrane (internal membranes included), not that it faces outward. Listed for comparison, not counted. One dataset here is instead an intact-cell label that reaches the inner side of the membrane, marked Inner-side labeling. not counted cells broken open and membranes purified, so it can't show a protein faces outward | |
Chordoma organelle fractionation, plasma-membrane fraction | 2024 | Membrane fractionation | Membrane fractionation | Chordoma cell lines Solid tumors | 4,109 | 17%17% of this dataset's proteins are Canonical or Likely in our Surfaceome. | Membrane fractionMembrane fraction: cells broken open and membranes purified, so it shows a protein is on a membrane (internal membranes included), not that it faces outward. Listed for comparison, not counted. One dataset here is instead an intact-cell label that reaches the inner side of the membrane, marked Inner-side labeling. not counted cells broken open and membranes purified, so it can't show a protein faces outward | |
Ewing sarcoma PDX/CDX surface-enriched proteome | 2024 | Membrane fractionation | Membrane fractionation | Ewing sarcoma PDX/CDX Solid tumors | 2,504 | 20%20% of this dataset's proteins are Canonical or Likely in our Surfaceome. | Membrane fractionMembrane fraction: cells broken open and membranes purified, so it shows a protein is on a membrane (internal membranes included), not that it faces outward. Listed for comparison, not counted. One dataset here is instead an intact-cell label that reaches the inner side of the membrane, marked Inner-side labeling. not counted cells broken open and membranes purified, so it can't show a protein faces outward | |
Trophoblast APEX | 2024 | Intact-cell labeling | Proximity labelingPeroxidase or laccase proximity labeling | BeWo placental choriocarcinoma/trophoblast model; cytotrophoblast versus syncytiotrophoblast differentiation Solid tumors | 287 | 38%38% of this dataset's proteins are Canonical or Likely in our Surfaceome; datasets without published amounts need at least 20% of their proteins (the tick), or are Provisional within 2 points below it. | Inner-side labelingMembrane fraction: cells broken open and membranes purified, so it shows a protein is on a membrane (internal membranes included), not that it faces outward. Listed for comparison, not counted. One dataset here is instead an intact-cell label that reaches the inner side of the membrane, marked Inner-side labeling. not counted labeling reaches the inner side of the membrane | |
U937 and HIV-1-latent U1 monocytic plasma-membrane fraction, iTRAQ 8-plex | 2024 | Membrane fractionation | Membrane fractionation | Cancer cell line Blood cancers | 2,975 | 15%15% of this dataset's proteins are Canonical or Likely in our Surfaceome. | Membrane fractionMembrane fraction: cells broken open and membranes purified, so it shows a protein is on a membrane (internal membranes included), not that it faces outward. Listed for comparison, not counted. One dataset here is instead an intact-cell label that reaches the inner side of the membrane, marked Inner-side labeling. not counted cells broken open and membranes purified, so it can't show a protein faces outward | |
Composition of raft-like cell membrane microdomains resistant to styrene-maleic acid copolymer (SMA) solubilization | 2023 | 2 datasets: 0 counted, 2 not counted | ||||||
HeLa whole-membrane proteome by metal-organic-layer adsorption and membrane fusion | 2023 | Membrane fractionation | Membrane fractionation | Cervical cancer cell line Solid tumors | 9,701 | 9%9% of this dataset's proteins are Canonical or Likely in our Surfaceome. | Membrane fractionMembrane fraction: cells broken open and membranes purified, so it shows a protein is on a membrane (internal membranes included), not that it faces outward. Listed for comparison, not counted. One dataset here is instead an intact-cell label that reaches the inner side of the membrane, marked Inner-side labeling. not counted cells broken open and membranes purified, so it can't show a protein faces outward | |
RD rhabdomyosarcoma enriched-membrane iTRAQ, mock reference channel | 2023 | Membrane fractionation | Membrane fractionation | Rhabdomyosarcoma cell line Solid tumors | 2,892 | 17%17% of this dataset's proteins are Canonical or Likely in our Surfaceome. | Membrane fractionMembrane fraction: cells broken open and membranes purified, so it shows a protein is on a membrane (internal membranes included), not that it faces outward. Listed for comparison, not counted. One dataset here is instead an intact-cell label that reaches the inner side of the membrane, marked Inner-side labeling. not counted cells broken open and membranes purified, so it can't show a protein faces outward | |
Rhabdomyosarcoma proteomics 2023 Study list, tab “rms-2023”PRIDE PXD039480: raw files | 2023 | Membrane fractionation | Membrane fractionation | Rhabdomyosarcoma cell lines and patient-derived xenografts; myoblast and MRC-5 controls; membrane fractions Solid tumors | 6,610 | 12%12% of this dataset's proteins are Canonical or Likely in our Surfaceome. | Membrane fractionMembrane fraction: cells broken open and membranes purified, so it shows a protein is on a membrane (internal membranes included), not that it faces outward. Listed for comparison, not counted. One dataset here is instead an intact-cell label that reaches the inner side of the membrane, marked Inner-side labeling. not counted cells broken open and membranes purified, so it can't show a protein faces outward | |
Pheochromocytoma/paraganglioma and adrenal medulla hpTC membrane transmembrane peptides | 2023 | Membrane fractionation | Membrane fractionation | Primary tumor tissue (PPGL) and normal adrenal medulla Solid tumors | 2,158 | 19%19% of this dataset's proteins are Canonical or Likely in our Surfaceome. | Membrane fractionMembrane fraction: cells broken open and membranes purified, so it shows a protein is on a membrane (internal membranes included), not that it faces outward. Listed for comparison, not counted. One dataset here is instead an intact-cell label that reaches the inner side of the membrane, marked Inner-side labeling. not counted cells broken open and membranes purified, so it can't show a protein faces outward | |
PC3 G0 and G1 sorted cells, Mem-PER Plus membranes | 2023 | Membrane fractionation | Membrane fractionation | Prostate cancer line Solid tumors | 3,721 | 8%8% of this dataset's proteins are Canonical or Likely in our Surfaceome. | Membrane fractionMembrane fraction: cells broken open and membranes purified, so it shows a protein is on a membrane (internal membranes included), not that it faces outward. Listed for comparison, not counted. One dataset here is instead an intact-cell label that reaches the inner side of the membrane, marked Inner-side labeling. not counted cells broken open and membranes purified, so it can't show a protein faces outward | |
HeLa, Panc-1 and pancreatic stellate cell peptidisc membrane libraries | 2023 | Membrane fractionation | Membrane fractionation | Cancer cell lines and non-malignant pancreatic stellate cell line Solid tumors | 2,133 | 17%17% of this dataset's proteins are Canonical or Likely in our Surfaceome. | Membrane fractionMembrane fraction: cells broken open and membranes purified, so it shows a protein is on a membrane (internal membranes included), not that it faces outward. Listed for comparison, not counted. One dataset here is instead an intact-cell label that reaches the inner side of the membrane, marked Inner-side labeling. not counted cells broken open and membranes purified, so it can't show a protein faces outward | |
Arachidonic acid, a clinically adverse mediator in the ovarian cancer microenvironment, impairs JAK-STAT signaling in macrophages by perturbing lipid raft structures | 2022 | 3 datasets: 0 counted, 3 not counted | ||||||
Human liver plasma-membrane fraction, ProteinPilot identification list | 2022 | Membrane fractionation | Membrane fractionation | Liver tissue Other normal cells | 1,228 | 15%15% of this dataset's proteins are Canonical or Likely in our Surfaceome. | Membrane fractionMembrane fraction: cells broken open and membranes purified, so it shows a protein is on a membrane (internal membranes included), not that it faces outward. Listed for comparison, not counted. One dataset here is instead an intact-cell label that reaches the inner side of the membrane, marked Inner-side labeling. not counted cells broken open and membranes purified, so it can't show a protein faces outward | |
Mesenchymal stem cells from dental pulp, adipose, bone marrow and hair follicle, plasma-membrane fraction Study list, tab “akpinar-msc-pm-2021”raw data not deposited | 2021 | Membrane fractionation | Membrane fractionation | Primary mesenchymal stem cells (cultured) Stem & stromal | 2,341 | 12%12% of this dataset's proteins are Canonical or Likely in our Surfaceome. | Membrane fractionMembrane fraction: cells broken open and membranes purified, so it shows a protein is on a membrane (internal membranes included), not that it faces outward. Listed for comparison, not counted. One dataset here is instead an intact-cell label that reaches the inner side of the membrane, marked Inner-side labeling. not counted cells broken open and membranes purified, so it can't show a protein faces outward | |
NCI-H23 lung adenocarcinoma microsomal fractions, 2D and 3D culture Study list, tab “kaczmarczyk-h23-2021”raw data not deposited | 2021 | Membrane fractionation | Membrane fractionation | Lung adenocarcinoma cell line Solid tumors | 4,765 | 8%8% of this dataset's proteins are Canonical or Likely in our Surfaceome. | Membrane fractionMembrane fraction: cells broken open and membranes purified, so it shows a protein is on a membrane (internal membranes included), not that it faces outward. Listed for comparison, not counted. One dataset here is instead an intact-cell label that reaches the inner side of the membrane, marked Inner-side labeling. not counted cells broken open and membranes purified, so it can't show a protein faces outward | |
MOLM-14 AML sucrose-gradient plasma-membrane fraction, three instruments | 2021 | Membrane fractionation | Membrane fractionation | Acute myeloid leukemia cell line Blood cancers | 5,973 | 11%11% of this dataset's proteins are Canonical or Likely in our Surfaceome. | Membrane fractionMembrane fraction: cells broken open and membranes purified, so it shows a protein is on a membrane (internal membranes included), not that it faces outward. Listed for comparison, not counted. One dataset here is instead an intact-cell label that reaches the inner side of the membrane, marked Inner-side labeling. not counted cells broken open and membranes purified, so it can't show a protein faces outward | |
K562 MEM-PER membrane-fraction N-glycoproteome, TMT Study list, tab “nayak-k562-memper-glyco-2021”raw data not deposited | 2021 | Membrane fractionation | Membrane fractionation | Leukemia cell line Blood cancers | 477 | 42%42% of this dataset's proteins are Canonical or Likely in our Surfaceome. | Membrane fractionMembrane fraction: cells broken open and membranes purified, so it shows a protein is on a membrane (internal membranes included), not that it faces outward. Listed for comparison, not counted. One dataset here is instead an intact-cell label that reaches the inner side of the membrane, marked Inner-side labeling. not counted cells broken open and membranes purified, so it can't show a protein faces outward | |
Erythrocyte membrane microdomain (detergent-resistant membrane) proteome | 2021 | Membrane fractionation | Membrane fractionation | Primary erythrocytes Other normal cells | 173 | 22%22% of this dataset's proteins are Canonical or Likely in our Surfaceome. | Membrane fractionMembrane fraction: cells broken open and membranes purified, so it shows a protein is on a membrane (internal membranes included), not that it faces outward. Listed for comparison, not counted. One dataset here is instead an intact-cell label that reaches the inner side of the membrane, marked Inner-side labeling. not counted cells broken open and membranes purified, so it can't show a protein faces outward | |
Breast cancer and MCF10A Mem-PER Plus membranes | 2021 | Membrane fractionation | Membrane fractionation | Breast cancer and epithelial lines Solid tumors | 1,400 | 21%21% of this dataset's proteins are Canonical or Likely in our Surfaceome. | Membrane fractionMembrane fraction: cells broken open and membranes purified, so it shows a protein is on a membrane (internal membranes included), not that it faces outward. Listed for comparison, not counted. One dataset here is instead an intact-cell label that reaches the inner side of the membrane, marked Inner-side labeling. not counted cells broken open and membranes purified, so it can't show a protein faces outward | |
Periodontal-ligament fibroblast membrane-enriched fraction | 2019 | Membrane fractionation | Membrane fractionation | Primary periodontal ligament fibroblasts Other normal cells | 925 | 16%16% of this dataset's proteins are Canonical or Likely in our Surfaceome. | Membrane fractionMembrane fraction: cells broken open and membranes purified, so it shows a protein is on a membrane (internal membranes included), not that it faces outward. Listed for comparison, not counted. One dataset here is instead an intact-cell label that reaches the inner side of the membrane, marked Inner-side labeling. not counted cells broken open and membranes purified, so it can't show a protein faces outward | |
hCMEC/D3 and HBMEC/cib brain microvascular endothelial plasma membrane fraction (jPOST JPST000531) | 2019 | Membrane fractionation | Membrane fractionation | Immortalized primary brain endothelial cell lines Other normal cells | 2,356 | 14%14% of this dataset's proteins are Canonical or Likely in our Surfaceome. | Membrane fractionMembrane fraction: cells broken open and membranes purified, so it shows a protein is on a membrane (internal membranes included), not that it faces outward. Listed for comparison, not counted. One dataset here is instead an intact-cell label that reaches the inner side of the membrane, marked Inner-side labeling. not counted cells broken open and membranes purified, so it can't show a protein faces outward | |
Post-mortem frontal cortex membrane-enriched fraction, control/AsymAD/AD | 2019 | Membrane fractionation | Membrane fractionation | Post-mortem brain tissue Neural cells | 1,739 | 13%13% of this dataset's proteins are Canonical or Likely in our Surfaceome. | Membrane fractionMembrane fraction: cells broken open and membranes purified, so it shows a protein is on a membrane (internal membranes included), not that it faces outward. Listed for comparison, not counted. One dataset here is instead an intact-cell label that reaches the inner side of the membrane, marked Inner-side labeling. not counted cells broken open and membranes purified, so it can't show a protein faces outward | |
Human B-cell lymphoma cell carbonate-washed membrane proteome by hpTC (Vit et al. 2019, Pitchfork) | 2019 | Membrane fractionation | Membrane fractionation | Cancer cell line Blood cancers | 1,717 | 11%11% of this dataset's proteins are Canonical or Likely in our Surfaceome. | Membrane fractionMembrane fraction: cells broken open and membranes purified, so it shows a protein is on a membrane (internal membranes included), not that it faces outward. Listed for comparison, not counted. One dataset here is instead an intact-cell label that reaches the inner side of the membrane, marked Inner-side labeling. not counted cells broken open and membranes purified, so it can't show a protein faces outward | |
Five tumor lines, native membrane protein extraction kit fractions Study list, tab “gu-tumorlines-2018”raw data not deposited | 2018 | Membrane fractionation | Membrane fractionation | Carcinoma cell lines (lung, liver, gastric, ovarian) Solid tumors | 5,746 | 13%13% of this dataset's proteins are Canonical or Likely in our Surfaceome. | Membrane fractionMembrane fraction: cells broken open and membranes purified, so it shows a protein is on a membrane (internal membranes included), not that it faces outward. Listed for comparison, not counted. One dataset here is instead an intact-cell label that reaches the inner side of the membrane, marked Inner-side labeling. not counted cells broken open and membranes purified, so it can't show a protein faces outward | |
HeLa plasma-membrane fragments from polydopamine-encapsulated, magnetically captured cells Study list, tab “liu-hela-pda-2018”raw data not deposited | 2018 | Membrane fractionation | Membrane fractionation | Cervical cancer cell line Solid tumors | 1,795 | 7%7% of this dataset's proteins are Canonical or Likely in our Surfaceome. | Membrane fractionMembrane fraction: cells broken open and membranes purified, so it shows a protein is on a membrane (internal membranes included), not that it faces outward. Listed for comparison, not counted. One dataset here is instead an intact-cell label that reaches the inner side of the membrane, marked Inner-side labeling. not counted cells broken open and membranes purified, so it can't show a protein faces outward | |
AML and donor CD34+CD123+ progenitor Mem-PER Plus membranes | 2018 | Membrane fractionation | Membrane fractionation | Primary AML and donor progenitors Blood cancers | 966 | 8%8% of this dataset's proteins are Canonical or Likely in our Surfaceome. | Membrane fractionMembrane fraction: cells broken open and membranes purified, so it shows a protein is on a membrane (internal membranes included), not that it faces outward. Listed for comparison, not counted. One dataset here is instead an intact-cell label that reaches the inner side of the membrane, marked Inner-side labeling. not counted cells broken open and membranes purified, so it can't show a protein faces outward | |
Human embryonic stem cell sucrose-centrifugation membrane fraction, two batches | 2018 | Membrane fractionation | Membrane fractionation | Embryonic stem cells Stem & stromal | 7,796 | 13%13% of this dataset's proteins are Canonical or Likely in our Surfaceome. | Membrane fractionMembrane fraction: cells broken open and membranes purified, so it shows a protein is on a membrane (internal membranes included), not that it faces outward. Listed for comparison, not counted. One dataset here is instead an intact-cell label that reaches the inner side of the membrane, marked Inner-side labeling. not counted cells broken open and membranes purified, so it can't show a protein faces outward | |
A novel approach to analyze lysosomal dysfunctions through subcellular proteomics and lipidomics: the case of NPC1 deficiency | 2017 | 3 datasets: 0 counted, 3 not counted | ||||||
HeLa (wt/F508del CFTR) detergent-resistant lipid-raft microdomains, SILAC Study list, tab “chhuon-hela-raft-2016”raw data not deposited | 2016 | Membrane fractionation | Membrane fractionation | Cancer cell line (engineered) Solid tumors | 331 | 24%24% of this dataset's proteins are Canonical or Likely in our Surfaceome. | Membrane fractionMembrane fraction: cells broken open and membranes purified, so it shows a protein is on a membrane (internal membranes included), not that it faces outward. Listed for comparison, not counted. One dataset here is instead an intact-cell label that reaches the inner side of the membrane, marked Inner-side labeling. not counted cells broken open and membranes purified, so it can't show a protein faces outward | |
Analysis of the proteins associated with platelet detergent resistant membranes | 2016 | 2 datasets: 0 counted, 2 not counted | ||||||
Gastric cancer and adjacent normal tissue plasma-membrane fraction, TMT Study list, tab “gao-gastric-pm-2015”raw data not deposited | 2015 | Membrane fractionation | Membrane fractionation | Primary gastric tissue (tumor and adjacent normal) Solid tumors | 490 | 18%18% of this dataset's proteins are Canonical or Likely in our Surfaceome. | Membrane fractionMembrane fraction: cells broken open and membranes purified, so it shows a protein is on a membrane (internal membranes included), not that it faces outward. Listed for comparison, not counted. One dataset here is instead an intact-cell label that reaches the inner side of the membrane, marked Inner-side labeling. not counted cells broken open and membranes purified, so it can't show a protein faces outward | |
Human cardiac stem cell plasma-membrane-enriched fraction | 2015 | Membrane fractionation | Membrane fractionation | Primary cardiac stem cells Stem & stromal | 2,971 | 16%16% of this dataset's proteins are Canonical or Likely in our Surfaceome. | Membrane fractionMembrane fraction: cells broken open and membranes purified, so it shows a protein is on a membrane (internal membranes included), not that it faces outward. Listed for comparison, not counted. One dataset here is instead an intact-cell label that reaches the inner side of the membrane, marked Inner-side labeling. not counted cells broken open and membranes purified, so it can't show a protein faces outward | |
Bone-marrow MSC and perivascular-cell membrane fraction Study list, tab “holley-msc-2015”raw data not deposited | 2015 | Membrane fractionation | Membrane fractionation | Primary mesenchymal stromal cells Stem & stromal | 5,462 | 12%12% of this dataset's proteins are Canonical or Likely in our Surfaceome. | Membrane fractionMembrane fraction: cells broken open and membranes purified, so it shows a protein is on a membrane (internal membranes included), not that it faces outward. Listed for comparison, not counted. One dataset here is instead an intact-cell label that reaches the inner side of the membrane, marked Inner-side labeling. not counted cells broken open and membranes purified, so it can't show a protein faces outward | |
Normal colon organoid plasma-membrane kit fraction Study list, tab “jung-colonorg-2015”raw data not deposited | 2015 | Membrane fractionation | Membrane fractionation | Normal colon organoids Other normal cells | 1,890 | 10%10% of this dataset's proteins are Canonical or Likely in our Surfaceome. | Membrane fractionMembrane fraction: cells broken open and membranes purified, so it shows a protein is on a membrane (internal membranes included), not that it faces outward. Listed for comparison, not counted. One dataset here is instead an intact-cell label that reaches the inner side of the membrane, marked Inner-side labeling. not counted cells broken open and membranes purified, so it can't show a protein faces outward | |
NSCLC tumor tissue and cell line membrane fractions | 2015 | Membrane fractionation | Membrane fractionation | Tumor tissue; cancer cell lines Solid tumors | 4,599 | 19%19% of this dataset's proteins are Canonical or Likely in our Surfaceome. | Membrane fractionMembrane fraction: cells broken open and membranes purified, so it shows a protein is on a membrane (internal membranes included), not that it faces outward. Listed for comparison, not counted. One dataset here is instead an intact-cell label that reaches the inner side of the membrane, marked Inner-side labeling. not counted cells broken open and membranes purified, so it can't show a protein faces outward | |
Human fetal ventricular cardiomyocyte cationic-silica membrane fraction | 2015 | Membrane fractionation | Membrane fractionation | Primary fetal cardiomyocytes Other normal cells | 1,343 | 10%10% of this dataset's proteins are Canonical or Likely in our Surfaceome. | Membrane fractionMembrane fraction: cells broken open and membranes purified, so it shows a protein is on a membrane (internal membranes included), not that it faces outward. Listed for comparison, not counted. One dataset here is instead an intact-cell label that reaches the inner side of the membrane, marked Inner-side labeling. not counted cells broken open and membranes purified, so it can't show a protein faces outward | |
Human liver tissue and isolated hepatocyte crude membrane fractions | 2015 | Membrane fractionation | Membrane fractionation | Primary liver tissue and primary hepatocytes Other normal cells | 4,827 | 12%12% of this dataset's proteins are Canonical or Likely in our Surfaceome. | Membrane fractionMembrane fraction: cells broken open and membranes purified, so it shows a protein is on a membrane (internal membranes included), not that it faces outward. Listed for comparison, not counted. One dataset here is instead an intact-cell label that reaches the inner side of the membrane, marked Inner-side labeling. not counted cells broken open and membranes purified, so it can't show a protein faces outward | |
Primary human colonic epithelial cell membrane fraction along four colon segments | 2014 | Membrane fractionation | Membrane fractionation | Primary tissue-derived epithelial cells (colon biopsies) Other normal cells | 2,602 | 18%18% of this dataset's proteins are Canonical or Likely in our Surfaceome. | Membrane fractionMembrane fraction: cells broken open and membranes purified, so it shows a protein is on a membrane (internal membranes included), not that it faces outward. Listed for comparison, not counted. One dataset here is instead an intact-cell label that reaches the inner side of the membrane, marked Inner-side labeling. not counted cells broken open and membranes purified, so it can't show a protein faces outward | |
Primary AML CD34+/CD34- blast membrane fraction Study list, tab “bonardi-aml-pm-2013”raw data not deposited | 2013 | Membrane fractionation | Membrane fractionation | Primary leukemia (AML) cells Blood cancers | 6,336 | 13%13% of this dataset's proteins are Canonical or Likely in our Surfaceome. | Membrane fractionMembrane fraction: cells broken open and membranes purified, so it shows a protein is on a membrane (internal membranes included), not that it faces outward. Listed for comparison, not counted. One dataset here is instead an intact-cell label that reaches the inner side of the membrane, marked Inner-side labeling. not counted cells broken open and membranes purified, so it can't show a protein faces outward | |
RPMI 8226 myeloma cationic nanoparticle pellicle plasma-membrane fractions Study list, tab “choksawangkarn-rpmi8226-pellicl”raw data not deposited | 2013 | Membrane fractionation | Membrane fractionation | Multiple myeloma cell line Blood cancers | 1,130 | 8%8% of this dataset's proteins are Canonical or Likely in our Surfaceome. | Membrane fractionMembrane fraction: cells broken open and membranes purified, so it shows a protein is on a membrane (internal membranes included), not that it faces outward. Listed for comparison, not counted. One dataset here is instead an intact-cell label that reaches the inner side of the membrane, marked Inner-side labeling. not counted cells broken open and membranes purified, so it can't show a protein faces outward | |
Pooled breast cancer tissue membrane fraction, iTRAQ | 2013 | Membrane fractionation | Membrane fractionation | Primary tumor tissue Solid tumors | 7,607 | 15%15% of this dataset's proteins are Canonical or Likely in our Surfaceome. | Membrane fractionMembrane fraction: cells broken open and membranes purified, so it shows a protein is on a membrane (internal membranes included), not that it faces outward. Listed for comparison, not counted. One dataset here is instead an intact-cell label that reaches the inner side of the membrane, marked Inner-side labeling. not counted cells broken open and membranes purified, so it can't show a protein faces outward | |
HepaRG undifferentiated and differentiated plasma-membrane fraction Study list, tab “petrareanu-heparg-2013”raw data not deposited | 2013 | Membrane fractionation | Membrane fractionation | Hepatic progenitor cell line Stem & stromal | 323 | 9%9% of this dataset's proteins are Canonical or Likely in our Surfaceome. | Membrane fractionMembrane fraction: cells broken open and membranes purified, so it shows a protein is on a membrane (internal membranes included), not that it faces outward. Listed for comparison, not counted. One dataset here is instead an intact-cell label that reaches the inner side of the membrane, marked Inner-side labeling. not counted cells broken open and membranes purified, so it can't show a protein faces outward | |
Primary neutrophil plasma membrane fraction from Percoll subcellular fractionation | 2013 | Membrane fractionation | Membrane fractionation | Primary neutrophils Immune cells | 1,298 | 15%15% of this dataset's proteins are Canonical or Likely in our Surfaceome. | Membrane fractionMembrane fraction: cells broken open and membranes purified, so it shows a protein is on a membrane (internal membranes included), not that it faces outward. Listed for comparison, not counted. One dataset here is instead an intact-cell label that reaches the inner side of the membrane, marked Inner-side labeling. not counted cells broken open and membranes purified, so it can't show a protein faces outward | |
Placental plasma membrane N-glycosites, sucrose-gradient PM then lectin capture Study list, tab “wang-placenta-2013”raw data not deposited | 2013 | Membrane fractionation | Membrane fractionation | Primary tissue (term placenta) Other normal cells | 538 | 46%46% of this dataset's proteins are Canonical or Likely in our Surfaceome. | Membrane fractionMembrane fraction: cells broken open and membranes purified, so it shows a protein is on a membrane (internal membranes included), not that it faces outward. Listed for comparison, not counted. One dataset here is instead an intact-cell label that reaches the inner side of the membrane, marked Inner-side labeling. not counted cells broken open and membranes purified, so it can't show a protein faces outward | |
Post-mortem insular cortex Triton X-114 detergent phase Study list, tab “english-brain-2012”raw data not deposited | 2012 | Membrane fractionation | Membrane fractionation | Post-mortem human brain tissue Neural cells | 1,130 | 12%12% of this dataset's proteins are Canonical or Likely in our Surfaceome. | Membrane fractionMembrane fraction: cells broken open and membranes purified, so it shows a protein is on a membrane (internal membranes included), not that it faces outward. Listed for comparison, not counted. One dataset here is instead an intact-cell label that reaches the inner side of the membrane, marked Inner-side labeling. not counted cells broken open and membranes purified, so it can't show a protein faces outward | |
Primary human fetal nucleated red blood cell membrane fraction Study list, tab “ponnusamy-fnrbc-membrane-2012”raw data not deposited | 2012 | Membrane fractionation | Membrane fractionation | Primary fetal blood cells Other normal cells | 226 | 11%11% of this dataset's proteins are Canonical or Likely in our Surfaceome. | Membrane fractionMembrane fraction: cells broken open and membranes purified, so it shows a protein is on a membrane (internal membranes included), not that it faces outward. Listed for comparison, not counted. One dataset here is instead an intact-cell label that reaches the inner side of the membrane, marked Inner-side labeling. not counted cells broken open and membranes purified, so it can't show a protein faces outward | |
Lung adenocarcinoma and paired normal lung tissue plasma-membrane fraction, iTRAQ Study list, tab “zhang-luad-pm-2012”raw data not deposited | 2012 | Membrane fractionation | Membrane fractionation | Primary lung tissue (adenocarcinoma and paired normal) Solid tumors | 270 | 32%32% of this dataset's proteins are Canonical or Likely in our Surfaceome. | Membrane fractionMembrane fraction: cells broken open and membranes purified, so it shows a protein is on a membrane (internal membranes included), not that it faces outward. Listed for comparison, not counted. One dataset here is instead an intact-cell label that reaches the inner side of the membrane, marked Inner-side labeling. not counted cells broken open and membranes purified, so it can't show a protein faces outward | |
MCF-7 sucrose-gradient plasma-membrane fraction Study list, tab “qattan-mcf7-sucrose-2010”raw data not deposited | 2010 | Membrane fractionation | Membrane fractionation | Breast carcinoma cell line Solid tumors | 1,451 | 12%12% of this dataset's proteins are Canonical or Likely in our Surfaceome. | Membrane fractionMembrane fraction: cells broken open and membranes purified, so it shows a protein is on a membrane (internal membranes included), not that it faces outward. Listed for comparison, not counted. One dataset here is instead an intact-cell label that reaches the inner side of the membrane, marked Inner-side labeling. not counted cells broken open and membranes purified, so it can't show a protein faces outward | |
Osteosarcoma vs osteoblast plasma membrane, two-phase partition Study list, tab “zhang-os-2010”raw data not deposited | 2010 | Membrane fractionation | Membrane fractionation | Osteosarcoma line and immortalized fetal osteoblasts Solid tumors | 287 | 36%36% of this dataset's proteins are Canonical or Likely in our Surfaceome. | Membrane fractionMembrane fraction: cells broken open and membranes purified, so it shows a protein is on a membrane (internal membranes included), not that it faces outward. Listed for comparison, not counted. One dataset here is instead an intact-cell label that reaches the inner side of the membrane, marked Inner-side labeling. not counted cells broken open and membranes purified, so it can't show a protein faces outward | |
Term placenta syncytiotrophoblast light apical plasma-membrane fraction Study list, tab “zhang-placenta-stb-2010”raw data not deposited | 2010 | Membrane fractionation | Membrane fractionation | Primary tissue (term placenta) Other normal cells | 280 | 31%31% of this dataset's proteins are Canonical or Likely in our Surfaceome. | Membrane fractionMembrane fraction: cells broken open and membranes purified, so it shows a protein is on a membrane (internal membranes included), not that it faces outward. Listed for comparison, not counted. One dataset here is instead an intact-cell label that reaches the inner side of the membrane, marked Inner-side labeling. not counted cells broken open and membranes purified, so it can't show a protein faces outward | |
MDA-MB-435 isogenic sublines SILAC plasma-membrane purifications Study list, tab “lethlarsen-mda-pm-2009”raw data not deposited | 2009 | Membrane fractionation | Membrane fractionation | Cancer cell line (MDA-MB-435 lineage; reported as breast cancer, melanoma-derived per later genotyping) Solid tumors | 913 | 14%14% of this dataset's proteins are Canonical or Likely in our Surfaceome. | Membrane fractionMembrane fraction: cells broken open and membranes purified, so it shows a protein is on a membrane (internal membranes included), not that it faces outward. Listed for comparison, not counted. One dataset here is instead an intact-cell label that reaches the inner side of the membrane, marked Inner-side labeling. not counted cells broken open and membranes purified, so it can't show a protein faces outward | |
Human embryonic stem cell membrane-enriched fraction, peptide IPG-IEF Study list, tab “mcquade-hesc-membrane-2009”raw data not deposited | 2009 | Membrane fractionation | Membrane fractionation | Embryonic stem cells Stem & stromal | 2,236 | 13%13% of this dataset's proteins are Canonical or Likely in our Surfaceome. | Membrane fractionMembrane fraction: cells broken open and membranes purified, so it shows a protein is on a membrane (internal membranes included), not that it faces outward. Listed for comparison, not counted. One dataset here is instead an intact-cell label that reaches the inner side of the membrane, marked Inner-side labeling. not counted cells broken open and membranes purified, so it can't show a protein faces outward | |
LNCaP/MyrAkt1 prostate cancer detergent-resistant membranes, two extraction methods Study list, tab “adam-lncap-drm-2008”raw data not deposited | 2008 | Membrane fractionation | Membrane fractionation | Prostate cancer cell line (engineered) Solid tumors | 503 | 9%9% of this dataset's proteins are Canonical or Likely in our Surfaceome. | Membrane fractionMembrane fraction: cells broken open and membranes purified, so it shows a protein is on a membrane (internal membranes included), not that it faces outward. Listed for comparison, not counted. One dataset here is instead an intact-cell label that reaches the inner side of the membrane, marked Inner-side labeling. not counted cells broken open and membranes purified, so it can't show a protein faces outward | |
hESC HUES-7 and hECC NT2/D1 plasma-membrane-enriched preparations Study list, tab “dormeyer-hesc-hecc-pm-2008”raw data not deposited | 2008 | Membrane fractionation | Membrane fractionation | Embryonic stem cell line and embryonal carcinoma cell line Stem & stromal | 1,572 | 23%23% of this dataset's proteins are Canonical or Likely in our Surfaceome. | Membrane fractionMembrane fraction: cells broken open and membranes purified, so it shows a protein is on a membrane (internal membranes included), not that it faces outward. Listed for comparison, not counted. One dataset here is instead an intact-cell label that reaches the inner side of the membrane, marked Inner-side labeling. not counted cells broken open and membranes purified, so it can't show a protein faces outward | |
Human liver tissue plasma membrane, original and carbonate-washed, shotgun Study list, tab “he-liver-pm-2007”raw data not deposited | 2007 | Membrane fractionation | Membrane fractionation | Primary tissue Other normal cells | 370 | 18%18% of this dataset's proteins are Canonical or Likely in our Surfaceome. | Membrane fractionMembrane fraction: cells broken open and membranes purified, so it shows a protein is on a membrane (internal membranes included), not that it faces outward. Listed for comparison, not counted. One dataset here is instead an intact-cell label that reaches the inner side of the membrane, marked Inner-side labeling. not counted cells broken open and membranes purified, so it can't show a protein faces outward | |
Caco-2 plasma and apical membrane fractions, proliferating and differentiated Study list, tab “pshezhetsky-caco2-pm-2007”raw data not deposited | 2007 | Membrane fractionation | Membrane fractionation | Cancer cell line Solid tumors | 1,085 | 13%13% of this dataset's proteins are Canonical or Likely in our Surfaceome. | Membrane fractionMembrane fraction: cells broken open and membranes purified, so it shows a protein is on a membrane (internal membranes included), not that it faces outward. Listed for comparison, not counted. One dataset here is instead an intact-cell label that reaches the inner side of the membrane, marked Inner-side labeling. not counted cells broken open and membranes purified, so it can't show a protein faces outward | |
Proteomic analysis of plasma membrane lipid rafts of HL-60 cells | 2007 | 2 datasets: 0 counted, 2 not counted | ||||||
Peripheral blood mononuclear cell plasma membranes by aqueous two-phase partitioning Study list, tab “everberg-pbmc-atps-2006”raw data not deposited | 2006 | Membrane fractionation | Membrane fractionation | Primary blood cells Immune cells | 224 | 23%23% of this dataset's proteins are Canonical or Likely in our Surfaceome. | Membrane fractionMembrane fraction: cells broken open and membranes purified, so it shows a protein is on a membrane (internal membranes included), not that it faces outward. Listed for comparison, not counted. One dataset here is instead an intact-cell label that reaches the inner side of the membrane, marked Inner-side labeling. not counted cells broken open and membranes purified, so it can't show a protein faces outward | |
Mitoxantrone-resistant MCF-7 (MXR) colloidal-silica pellicle plasma-membrane fraction Study list, tab “rahbar-mcf7mxr-pellicle-2005”raw data not deposited | 2005 | Membrane fractionation | Membrane fractionation | Breast cancer cell line (drug-resistant subline) Solid tumors | 526 | 29%29% of this dataset's proteins are Canonical or Likely in our Surfaceome. | Membrane fractionMembrane fraction: cells broken open and membranes purified, so it shows a protein is on a membrane (internal membranes included), not that it faces outward. Listed for comparison, not counted. One dataset here is instead an intact-cell label that reaches the inner side of the membrane, marked Inner-side labeling. not counted cells broken open and membranes purified, so it can't show a protein faces outward | |
Human neonatal epidermis plasma membrane, sucrose-gradient purification Study list, tab “blonder-epidermis-pm-2004”raw data not deposited | 2004 | Membrane fractionation | Membrane fractionation | Primary tissue (neonatal epidermis) Other normal cells | 1,258 | 20%20% of this dataset's proteins are Canonical or Likely in our Surfaceome. | Membrane fractionMembrane fraction: cells broken open and membranes purified, so it shows a protein is on a membrane (internal membranes included), not that it faces outward. Listed for comparison, not counted. One dataset here is instead an intact-cell label that reaches the inner side of the membrane, marked Inner-side labeling. not counted cells broken open and membranes purified, so it can't show a protein faces outward | |